| For: | Nosho K, Sukawa Y, Adachi Y, Ito M, Mitsuhashi K, Kurihara H, Kanno S, Yamamoto I, Ishigami K, Igarashi H, Maruyama R, Imai K, Yamamoto H, Shinomura Y. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World J Gastroenterol 2016; 22(2): 557-566 [PMID: 26811607 DOI: 10.3748/wjg.v22.i2.557] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i2/557.htm |
| Number | Citing Articles |
| 1 |
Narjess Bostanghadiri, Shabnam Razavi, Aref Shariati, Malihe Talebi, Shiva Mirkalantari, Amirnader Emami Razavi, Davood Darban-Sarokhalil. Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1302719
|
| 2 |
Mehdi Pezeshgi Modarres, Mohammad Amin Habibi, Mohammad Reza Pashaei, Yousef Mohammadpour, Kimia Jazi, Sajjad Ahmadpour. Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer. Current Cancer Therapy Reviews 2025; 21(1) doi: 10.2174/0115733947270529231116114913
|
| 3 |
Fabio Pagni, Elena Guerini-Rocco, Anne Maria Schultheis, Giulia Grazia, Erika Rijavec, Michele Ghidini, Gianluca Lopez, Konstantinos Venetis, Giorgio Alberto Croci, Umberto Malapelle, Nicola Fusco. Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers. International Journal of Molecular Sciences 2019; 20(21) doi: 10.3390/ijms20215452
|
| 4 |
Ke Wu, Yaorong Li, Kangli Ma, Weiguang Zhao, Zhixian Yao, Zhong Zheng, Feng Sun, Xingyu Mu, Zhihong Liu, Junhua Zheng. The microbiota and renal cell carcinoma. Cellular Oncology 2024; 47(2) doi: 10.1007/s13402-023-00876-9
|
| 5 |
Irene Mignini, Giulia Piccirilli, Linda Galasso, Fabrizio Termite, Giorgio Esposto, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential. Journal of Clinical Medicine 2024; 13(2) doi: 10.3390/jcm13020420
|
| 6 |
Yunze Li, Ying Yang, Xixia Zhang, Zhe Huang, Xiaoyue Zhang, Junxiong Wen. Colorectal cancer landscape from gut microbiota: Insights into mutations, epigenetic dysregulation, and immune microenvironment alterations. Virulence 2026; 17(1) doi: 10.1080/21505594.2026.2696642
|
| 7 |
Kayode Garraway, Chad M. Johannes, Angela Bryan, John Peauroi, Giacomo Rossi, Min Zhang, Chong Wang, Karin Allenspach, Albert E. Jergens. Relationship of the mucosal microbiota to gastrointestinal inflammation and small cell intestinal lymphoma in cats. Journal of Veterinary Internal Medicine 2018; 32(5) doi: 10.1111/jvim.15291
|
| 8 |
Raisha J. Gibbs, Adam C. Chambers, Darryl J. Hill. The emerging role of Fusobacteria in carcinogenesis. European Journal of Clinical Investigation 2024; 54(S2) doi: 10.1111/eci.14353
|
| 9 |
Zong Yawen, Cheng Xiangyun, Liao Binyou, Ye Xingchen, Liu Taiping, Zhou Xuedong, Li Jiyao, Cheng Lei, Xu Wenyue, Ren Biao. The dynamic landscape of parasitemia dependent intestinal microbiota shifting and the correlated gut transcriptome during Plasmodium yoelii infection. Microbiological Research 2022; 258 doi: 10.1016/j.micres.2022.126994
|
| 10 |
Cankun Wang, Anjun Ma, Yingjie Li, Megan E. McNutt, Shiqi Zhang, Jiangjiang Zhu, Rebecca Hoyd, Caroline E. Wheeler, Lary A. Robinson, Carlos H.F. Chan, Yousef Zakharia, Rebecca D. Dodd, Cornelia M. Ulrich, Sheetal Hardikar, Michelle L. Churchman, Ahmad A. Tarhini, Eric A. Singer, Alexandra P. Ikeguchi, Martin D. McCarter, Nicholas Denko, Gabriel Tinoco, Marium Husain, Ning Jin, Afaf E.G. Osman, Islam Eljilany, Aik Choon Tan, Samuel S. Coleman, Louis Denko, Gregory Riedlinger, Bryan P. Schneider, Daniel Spakowicz, Qin Ma. A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset. Cancer Research Communications 2024; 4(2) doi: 10.1158/2767-9764.CRC-23-0213
|
| 11 |
Ze-qiang Liu, Xiao-ying Yang, Jia-hong Chen, Si-cheng Ge, Shi-xue Dai, Sheng-huang Zhu, Zhi-yong Xian. From dysbiosis to precision therapy: decoding the gut-bladder axis in bladder carcinogenesis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1630726
|
| 12 |
Dan Yu, Xueshibojie Liu, Guanghong Han, Yan Liu, Xue Zhao, Di Wang, Xiaomin Bian, Tingting Gu, Lianji Wen. The let-7 family of microRNAs suppresses immune evasion in head and neck squamous cell carcinoma by promoting PD-L1 degradation. Cell Communication and Signaling 2019; 17(1) doi: 10.1186/s12964-019-0490-8
|
| 13 |
Yuxi Cheng, Shenhan Yu, Yingyi Huang, Bin Liu. Engineered microorganisms and nanomaterials in cancer therapy: Emerging hybrid systems and translational challenges. Nanomedicine: Nanotechnology, Biology and Medicine 2026; 76 doi: 10.1016/j.nano.2026.103002
|
| 14 |
Marcela Alcântara Proença, Joice Matos Biselli, Maysa Succi, Fábio Eduardo Severino, Gustavo Noriz Berardinelli, Alaor Caetano, Rui Manuel Reis, David J Hughes, Ana Elizabete Silva. Relationship between <i>Fusobacterium nucleatum</i>, inflammatory mediators and microRNAs in colorectal carcinogenesis. World Journal of Gastroenterology 2018; 24(47): 5351-5365 doi: 10.3748/wjg.v24.i47.5351
|
| 15 |
Kinga Knop-Chodyła, Anna Kochanowska-Mazurek, Zuzanna Piasecka, Aneta Głaz, Ewelina Weronika Wesołek-Bielaska, Kinga Syty, Alicja Forma, Jacek Baj. Oral Microbiota and the Risk of Gastrointestinal Cancers—A Narrative Literature Review. Pathogens 2024; 13(9) doi: 10.3390/pathogens13090819
|
| 16 |
Hege Smith Tunsjø, Gro Gundersen, Fredrik Rangnes, John Christopher Noone, Alexander Endres, Vahid Bemanian. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients. European Journal of Clinical Microbiology & Infectious Diseases 2019; 38(7) doi: 10.1007/s10096-019-03562-7
|
| 17 |
B. Saberzadeh-Ardestani, N.R. Foster, H.E. Lee, Q. Shi, S.R. Alberts, T.C. Smyrk, F.A. Sinicrope. Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]. Annals of Oncology 2022; 33(11) doi: 10.1016/j.annonc.2022.07.1942
|
| 18 |
Bo-young Hong, Takayasu Ideta, Bruno S. Lemos, Yuichi Igarashi, Yuliana Tan, Michael DiSiena, Allen Mo, John W. Birk, Faripour Forouhar, Thomas J. Devers, George M. Weinstock, Daniel W. Rosenberg. Characterization of Mucosal Dysbiosis of Early Colonic Neoplasia. npj Precision Oncology 2019; 3(1) doi: 10.1038/s41698-019-0101-6
|
| 19 |
Cui Ma, Qiankun Gao, Wanghong Zhang, Qian Zhu, Wu Tang, Francois Blachier, Hao Ding, Xiangfeng Kong. Supplementing Synbiotic in Sows' Diets Modifies Beneficially Blood Parameters and Colonic Microbiota Composition and Metabolic Activity in Suckling Piglets. Frontiers in Veterinary Science 2020; 7 doi: 10.3389/fvets.2020.575685
|
| 20 |
John R Pluske, Diana L Turpin, Shafi Sahibzada, Lane Pineda, Yanming Han, Alison Collins. Impacts of feeding organic acid-based feed additives on diarrhea, performance, and fecal microbiome characteristics of pigs after weaning challenged with an enterotoxigenic strain of Escherichia coli
. Translational Animal Science 2021; 5(4) doi: 10.1093/tas/txab212
|
| 21 |
Jingpeng Yang, Hong Yang, Yanan Li. The triple interactions between gut microbiota, mycobiota and host immunity. Critical Reviews in Food Science and Nutrition 2023; 63(33) doi: 10.1080/10408398.2022.2094888
|
| 22 |
Reza Torkashvand, Bahareh Hajikhani, Reza Hosseini Doust, Hossein Dabiri, Masoud Dadashi. Associations Between Fusobacterium nucleatum and msh2, mlh1, and msh6 Gene Expression in Colorectal Cancer. Jundishapur Journal of Microbiology 2024; 17(2) doi: 10.5812/jjm-144247
|
| 23 |
Walaa K. Mousa, Aya Al Ali. The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2024; 25(20) doi: 10.3390/ijms252011259
|
| 24 |
Sara Daniela Gomes, Cláudia Suellen Oliveira, João Azevedo-Silva, Marta R. Casanova, Judite Barreto, Helena Pereira, Susana R. Chaves, Lígia R. Rodrigues, Margarida Casal, Manuela Côrte-Real, Fátima Baltazar, Ana Preto. The Role of Diet Related Short-Chain Fatty Acids in Colorectal Cancer Metabolism and Survival: Prevention and Therapeutic Implications. Current Medicinal Chemistry 2020; 27(24) doi: 10.2174/0929867325666180530102050
|
| 25 |
Muhammad-Afiq Osman, Hui-min Neoh, Nurul-Syakima Ab Mutalib, Siok-Fong Chin, Rahman Jamal. 16S rRNA Gene Sequencing for Deciphering the Colorectal Cancer Gut Microbiome: Current Protocols and Workflows. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00767
|
| 26 |
Fu-Mei Shang, Hong-Li Liu. <i>Fusobacterium nucleatum</i> and colorectal cancer: A review. World Journal of Gastrointestinal Oncology 2018; 10(3): 71-81 doi: 10.4251/wjgo.v10.i3.71
|
| 27 |
M. Fidelle, L. Derosa, B. Routy, L. Zitvogel. Contourner la résistance à l’immunothérapie des cancers : interventions centrées sur le microbiome intestinal. Bulletin de l'Académie Nationale de Médecine 2021; 205(4) doi: 10.1016/j.banm.2021.01.022
|
| 28 |
Marc Oliva, Nuria Mulet-Margalef, Maria Ochoa-De-Olza, Stefania Napoli, Joan Mas, Berta Laquente, Laia Alemany, Eric Duell, Paolo Nuciforo, Victor Moreno. Tumor-Associated Microbiome: Where Do We Stand?. International Journal of Molecular Sciences 2021; 22(3) doi: 10.3390/ijms22031446
|
| 29 |
Muhammad G. Kibriya, Farzana Jasmine, Joel Pekow, Aaron Munoz, Christopher Weber, Maruf Raza, Mohammed Kamal, Habibul Ahsan, Marc Bissonnette. Pathways Related to Colon Inflammation Are Associated with Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study. Cancers 2023; 15(11) doi: 10.3390/cancers15112921
|
| 30 |
Min Jin, Qilin Fan, Fumei Shang, Tao Zhang, Shuji Ogino, Hongli Liu. Fusobacteria alterations are associated with colorectal cancer liver metastasis and a poor prognosis. Oncology Letters 2024; 27(5) doi: 10.3892/ol.2024.14368
|
| 31 |
Suad A Al-Hilu, Wisam H Al-Shujairi. Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition. International Journal of Microbiology 2020; 2020 doi: 10.1155/2020/4639761
|
| 32 |
Fazhan Li, Jun Zhou, Zedong Li, Leiyi Zhang. Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers. Bioscience Reports 2021; 41(4) doi: 10.1042/BSR20203496
|
| 33 |
Martha Heusler, Rebekka Einenkel, Jens Ehrhardt, Damián Oscar Muzzio, Marek Zygmunt. Low Abundance Fusobacterium Nucleatum Supports Early Pregnancy Development – An In Vitro Study. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.698045
|
| 34 |
G. Jia, A. Zhi, P. F. H. Lai, G. Wang, Y. Xia, Z. Xiong, H. Zhang, N. Che, L. Ai. The oral microbiota – a mechanistic role for systemic diseases. British Dental Journal 2018; 224(6) doi: 10.1038/sj.bdj.2018.217
|
| 35 |
Katrine M. Johannesen, Shailesh B. Kolekar, Nikolaos Greve, Xiaohui Chen Nielsen, Toke Seierøe Barfod, Uffe Bodtger. Differences in mortality in Fusobacterium necrophorum and Fusobacterium nucleatum infections detected by culture and 16S rRNA gene sequencing. European Journal of Clinical Microbiology & Infectious Diseases 2019; 38(1) doi: 10.1007/s10096-018-3394-4
|
| 36 |
Yung-Yu Hsieh, Wen-Lin Kuo, Wan-Ting Hsu, Shui-Yi Tung, Chin Li. Fusobacterium Nucleatum-Induced Tumor Mutation Burden Predicts Poor Survival of Gastric Cancer Patients. Cancers 2022; 15(1) doi: 10.3390/cancers15010269
|
| 37 |
Jin Imai, Sho Kitamoto, Nobuhiko Kamada. The pathogenic oral–gut–liver axis: new understandings and clinical implications. Expert Review of Clinical Immunology 2021; 17(7) doi: 10.1080/1744666X.2021.1935877
|
| 38 |
Chaochao Xu, Lina Fan, Yifeng Lin, Weiyi Shen, Yadong Qi, Ying Zhang, Zhehang Chen, Lan Wang, Yanqin Long, Tongyao Hou, Jianmin Si, Shujie Chen.
Fusobacterium nucleatum
promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization
. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1980347
|
| 39 |
Oana Lelia Pop, Dan Cristian Vodnar, Zorita Diaconeasa, Magdalena Istrati, Adriana Bințințan, Vasile Virgil Bințințan, Ramona Suharoschi, Rosita Gabbianelli. An Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps. International Journal of Molecular Sciences 2020; 21(19) doi: 10.3390/ijms21197359
|
| 40 |
Shakhzada Ibragimova, Revathy Ramachandran, Fahad R. Ali, Leonard Lipovich, Samuel B. Ho. Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.725821
|
| 41 |
Anirudh P. Shanbhag. The Gut Microbiome in Precision Medicine. 2026; doi: 10.1016/B978-0-443-40483-2.00040-6
|
| 42 |
Chun‑Ting Ma, He‑Sheng Luo, Feng Gao, Qin‑Cai Tang, Wei Chen. Fusobacterium�nucleatum promotes the progression of colorectal cancer by interacting with E‑cadherin. Oncology Letters 2018; doi: 10.3892/ol.2018.8947
|
| 43 |
Elena Monica Borroni, Dorina Qehajaj, Floriana Maria Farina, Daniel Yiu, Robert S. Bresalier, Maurizio Chiriva-Internati, Leonardo Mirandola, Sanja Štifter, Luigi Laghi, Fabio Grizzi. Fusobacterium nucleatum and the Immune System in Colorectal Cancer. Current Colorectal Cancer Reports 2019; 15(5) doi: 10.1007/s11888-019-00442-2
|
| 44 |
Edda Russo, Federico Boem, Lavinia Curini, Amedeo Amedei. Gastrointestinal Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 4 doi: 10.1007/16833_2022_6
|
| 45 |
The Human Microbiome: An Invisible Key to Unlocking Wellness. Journal of Pure and Applied Microbiology 2025; 19(1) doi: 10.22207/JPAM.19.1.20
|
| 46 |
Asma Rafique, Young-Sang Koh.
Association of Fusobacterium nucleatum in the Progression of Colorectal Cancer
. Journal of Bacteriology and Virology 2021; 51(2) doi: 10.4167/jbv.2021.51.2.039
|
| 47 |
Jennifer Borowsky, Koichiro Haruki, Mai Chan Lau, Andressa Dias Costa, Juha P. Väyrynen, Tomotaka Ugai, Kota Arima, Annacarolina da Silva, Kristen D. Felt, Melissa Zhao, Carino Gurjao, Tyler S. Twombly, Kenji Fujiyoshi, Sara A. Väyrynen, Tsuyoshi Hamada, Kosuke Mima, Susan Bullman, Tabitha A. Harrison, Amanda I. Phipps, Ulrike Peters, Kimmie Ng, Jeffrey A. Meyerhardt, Mingyang Song, Edward L. Giovannucci, Kana Wu, Xuehong Zhang, Gordon J. Freeman, Curtis Huttenhower, Wendy S. Garrett, Andrew T. Chan, Barbara A. Leggett, Vicki L.J. Whitehall, Neal Walker, Ian Brown, Mark Bettington, Reiko Nishihara, Charles S. Fuchs, Jochen K. Lennerz, Marios Giannakis, Jonathan A. Nowak, Shuji Ogino. Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment. Clinical Cancer Research 2021; 27(10) doi: 10.1158/1078-0432.CCR-20-4009
|
| 48 |
Ji Ae Lee, Seung-Yeon Yoo, Hyeon Jeong Oh, Seorin Jeong, Nam-Yun Cho, Gyeong Hoon Kang, Jung Ho Kim. Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status. Cancer Immunology, Immunotherapy 2021; 70(1) doi: 10.1007/s00262-020-02657-x
|
| 49 |
Irati Romero-Garmendia, Koldo Garcia-Etxebarria. Host Genetics and Microbiota Interactions in Colorectal Cancer: Shared or Independent Risk?. Microorganisms 2022; 10(11) doi: 10.3390/microorganisms10112129
|
| 50 |
Shijia Pan, Yuan Guo, Fan Hong, Pengfei Xu, Yonggong Zhai. Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(1) doi: 10.1016/j.bbadis.2021.166281
|
| 51 |
Theresa Dregelies, Franziska Haumaier, William Sterlacci, Steffen Backert, Michael Vieth. Detection of Fusobacterium nucleatum in Patients with Colitis-Associated Colorectal Cancer. Current Microbiology 2023; 80(9) doi: 10.1007/s00284-023-03398-7
|
| 52 |
. 2023; doi: 10.70675/bdde7470z307dz42bfzb795zf574ce0f1d2b
|
| 53 |
Yingman Liu, Wenxuan Huang, Jiaqi Wang, Jiaojiao Ma, Manman Zhang, Xiaoying Lu, Jie Liu, Yurong Kou. Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.693479
|
| 54 |
Masakazu Hamada, Kyoko Nishiyama, Ryota Nomura, Tatsuya Akitomo, Chieko Mitsuhata, Yoshiaki Yura, Kazuhiko Nakano, Michiyo Matsumoto-Nakano, Narikazu Uzawa, Hiroaki Inaba. Clinical relationships between the intratumoral microbiome and risk factors for head and neck cancer. Heliyon 2024; 10(20) doi: 10.1016/j.heliyon.2024.e39284
|
| 55 |
Indranil Chattopadhyay, Ruby Dhar, Karthikeyan Pethusamy, Ashikh Seethy, Tryambak Srivastava, Ramkishor Sah, Jyoti Sharma, Subhradip Karmakar. Exploring the Role of Gut Microbiome in Colon Cancer. Applied Biochemistry and Biotechnology 2021; 193(6) doi: 10.1007/s12010-021-03498-9
|
| 56 |
Yunbo He, Jinliang Huang, Qiaorong Li, Weiping Xia, Chunyu Zhang, Zhi Liu, Jiatong Xiao, Zhenglin Yi, Hao Deng, Zicheng Xiao, Jiao Hu, Huihuang Li, Xiongbing Zu, Chao Quan, Jinbo Chen. Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy. Cancers 2022; 14(21) doi: 10.3390/cancers14215317
|
| 57 |
Efrat L Amitay, Simone Werner, Marius Vital, Dietmar H Pieper, Daniela Höfler, Indra-Jasmin Gierse, Julia Butt, Yesilda Balavarca, Katarina Cuk, Hermann Brenner. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study. Carcinogenesis 2017; 38(8) doi: 10.1093/carcin/bgx053
|
| 58 |
Bing Liu, Guimiao Jiang, Shihao Ge, Longtao Li, Min Li, Boying Dong, Chuanliang Ji, Yantao Wang, Zhaobin Fan, Fuwei Zhao. Comparison of the Fecal Bacterial Microbiota between Healthy and Diarrheic Donkey Foals. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4118225
|
| 59 |
Shi-Tong Wang, Wen-Qi Cui, Dan Pan, Min Jiang, Bing Chang, Li-Xuan Sang. Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer. World Journal of Gastroenterology 2020; 26(6): 562-597 doi: 10.3748/wjg.v26.i6.562
|
| 60 |
Ruyi Zhang, Xiang Zhang, Harry Cheuk Hay Lau, Jun Yu. Gut microbiota in cancer initiation, development and therapy. Science China Life Sciences 2025; 68(5) doi: 10.1007/s11427-024-2831-x
|
| 61 |
Han Shuwen, Yang Xi, Qi Quan, Pan Yuefen, Da Miao, Zhou Qing. Relationship Between Intestinal Microorganisms and T Lymphocytes In Colorectal Cancer. Future Oncology 2019; 15(14) doi: 10.2217/fon-2018-0595
|
| 62 |
Asma Rafique, Young-Sang Koh.
Association of Fusobacterium nucleatum in the Progression of Colorectal Cancer
. Journal of Bacteriology and Virology 2021; 51(2) doi: 10.4167/jbv.2021.51.2.39
|
| 63 |
Yang Shen, Jinlin Zhu, Zhaohong Deng, Wenwei Lu, Hongchao Wang. EnsDeepDP: An Ensemble Deep Learning Approach for Disease Prediction Through Metagenomics. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2023; 20(2) doi: 10.1109/TCBB.2022.3201295
|
| 64 |
Rieko Kanehara, Taiki Yamaji, Keishi Kameyama, Aya Kuchiba, Yasuo Kakugawa, Hiroaki Ikematsu, Kinichi Hotta, Masau Sekiguchi, Nozomu Kobayashi, Takahisa Matsuda, Motoki Iwasaki. The gut microbiota and colorectal lesions subtyped in adenoma-carcinoma sequence and serrated pathway. Cancer Epidemiology 2026; 103 doi: 10.1016/j.canep.2026.103134
|
| 65 |
Yimeng Li, Xiaolong Hu, Shuang Yang, Juntong Zhou, Lei Qi, Xiaoning Sun, Mengyuan Fan, Shanghua Xu, Muha Cha, Meishan Zhang, Shaobi Lin, Shuqiang Liu, Defu Hu. Comparison Between the Fecal Bacterial Microbiota of Healthy and Diarrheic Captive Musk Deer. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00300
|
| 66 |
Ke-Yang Wang, Xue-Qing Zhong. Overview of relationship between intestinal flora imbalance and diseases. World Chinese Journal of Digestology 2024; 32(4) doi: 10.11569/wcjd.v32.i4.280
Abstract(895) |
Core Tip(827) |
Full Article(HTML)(7470)
|
Times Cited (0)
|
Total Visits (8142)
|
Open
|
| 67 |
Xi Chen, Qing Guo, Ying-Ying Li, Tie-Ying Song, Jun-Qing Ge. Metagenomic analysis fecal microbiota of dysentery-like diarrhoea in a pig farm using next-generation sequencing. Frontiers in Veterinary Science 2023; 10 doi: 10.3389/fvets.2023.1257573
|
| 68 |
Jiante Li, Zhiliang Wei, Shougen Cao, Xiaojie Tan, Shanglong Liu, Zengwu Yao, Teng Sun, Yi Li, Dongfeng Zhang, Yanbing Zhou. A pilot study on clinicopathological features and intestinal microflora changes in colorectal cancer patients born over a nine-year period encompassing three years before and after the Great Chinese famine. Cancer Epidemiology 2019; 59 doi: 10.1016/j.canep.2019.02.001
|
| 69 |
Yung-Yu Hsieh, Shui-Yi Tung, Hung-Yu Pan, Chih-Wei Yen, Huang-Wei Xu, Ying-Jhen Lin, Yi-Fang Deng, Wan-Ting Hsu, Cheng-Shyong Wu, Chin Li. Increased Abundance of Clostridium and Fusobacterium in Gastric Microbiota of Patients with Gastric Cancer in Taiwan. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18596-0
|
| 70 |
Rongrong Li, Jilu Shen, Yuanhong Xu. Fusobacterium nucleatum and Colorectal Cancer. Infection and Drug Resistance 2022; doi: 10.2147/IDR.S357922
|
| 71 |
Yuto Hozaka, Hideyuki Oi, Souichi Satake, Yoshinori Uchino, Yuichi Goto, Tetsuya Idichi, Kiyonori Tanoue, Yoichi Yamasaki, Yota Kawasaki, Yuko Mataki, Hiroshi Kurahara, Akihiro Nakajo, Michiyo Higashi, Akihide Tanimoto, Tsuyoshi Sugiura, Takao Ohtsuka. Are intratumoral microbiota involved in the progression of intraductal papillary mucinous neoplasms of the pancreas?. Surgery 2023; 173(2) doi: 10.1016/j.surg.2022.10.003
|
| 72 |
Sepideh Fereshteh, Narjes Noori Goodarzi, Negin Bolourchi, Mahshid Khazani Asforooshani, Afsaneh Salimi, Farzad Badmasti. Uncovering the novel and putative immunogenic targets: Utilizing a reverse vaccinology approach against Fusobacterium nucleatum. Informatics in Medicine Unlocked 2023; 42 doi: 10.1016/j.imu.2023.101359
|
| 73 |
Alaa A. Mohamed, Basel K. al-Ramadi, Maria J. Fernandez-Cabezudo. Interplay between Microbiota and γδ T Cells: Insights into Immune Homeostasis and Neuro-Immune Interactions. International Journal of Molecular Sciences 2024; 25(3) doi: 10.3390/ijms25031747
|
| 74 |
Rodrigo Carvalho, Fillipe Carmo, Sara Heloisa, Barbara Cordeiro, Aline Vaz, Enrico Gimenez, Luis Goulart, Aristóteles Góes-Neto, Yves Le Loir, Gwénaël Jan, Vasco Azevedo. Metagenomics for Gut Microbes. 2018; doi: 10.5772/intechopen.72031
|
| 75 |
Sofia C Tortora, Vimal M Bodiwala, Andrew Quinn, Laura A Martello, Shivakumar Vignesh. Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences. World Journal of Gastrointestinal Oncology 2022; 14(2): 375-395 doi: 10.4251/wjgo.v14.i2.375
|
| 76 |
Shuji Ogino, Jonathan A. Nowak, Tsuyoshi Hamada, Danny A. Milner, Reiko Nishihara. Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology. Annual Review of Pathology: Mechanisms of Disease 2019; 14(1) doi: 10.1146/annurev-pathmechdis-012418-012818
|
| 77 |
Min Young Park, Guy D. Eslick. Gastrointestinal Diseases and their Associated Infections. 2019; doi: 10.1016/B978-0-323-54843-4.00009-X
|
| 78 |
Thorbjørn Søren Rønn Jensen, Badar Mahmood, Morten Bach Damm, Marie Balslev Backe, Mattias Salling Dahllöf, Steen Seier Poulsen, Mark Berner Hansen, Niels Bindslev. Combined activity of COX-1 and COX-2 is increased in non-neoplastic colonic mucosa from colorectal neoplasia patients. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0759-1
|
| 79 |
Kumar Ganesan, Songhe Guo, Sundaz Fayyaz, Ge Zhang, Baojun Xu. Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy. Cancers 2019; 11(10) doi: 10.3390/cancers11101592
|
| 80 |
Ángel Escudero-Jiménez, Jorge Galán-Ros, Francisco Huertas-López, Andrea Pérez-Sarabia, Diogo Ribeiro, Fátima Postigo-Corrales, Ana Albaladejo-González, María Isabel Díaz-López, María Dolores López-Abellán, José García-Rodríguez, María Asunción Beltrán-Videla, Ana Belén Arroyo, Ana María Hurtado López, Ana Tapia-Abellán, Rubén Corral San Miguel, Edith Rodríguez-Braun, Eduardo Feliciangeli, Alberto Sánchez-Espinosa, Ana Conesa, Ginés Luengo-Gil, Pablo Conesa-Zamora, Promi Das. Integrative microbiome–methylome analysis links bacterial taxa to colorectal cancer histological subtypes. mSystems 2026; 11(9) doi: 10.1128/msystems.00622-26
|
| 81 |
Veerasamy Ravichandran, Rohini Karunakaran, Smitha Vasu. Human Microbiome Drug Targets. 2025; doi: 10.1016/B978-0-443-15435-5.00007-4
|
| 82 |
Shigenobu Emoto, Ryo Inoue, Shin Murai, Yuriko Inagaki, Hiroaki Nozawa, Kazuhito Sasaki, Koji Murono, Kensuke Kaneko, Yuichiro Yokoyama, Shinya Abe, Yuzo Nagai, Takahide Shinagawa, Yuichi Tachikawa, Satoshi Okada, Takamitsu Tsukahara, Kai Ohashi, Masashi Ohno, Akira Andoh, Soichiro Ishihara. A pilot study of gut mucosal and faecal microbiota in rectal cancer: associations with histological response and adverse events following preoperative chemoradiotherapy. Colorectal Disease 2025; 27(5) doi: 10.1111/codi.70106
|
| 83 |
Wenjing Li, Yongwei Zeng, Jiayu Zhong, Youyu Hu, Xia Xiong, Yingshun Zhou, Li Fu. Probiotics Exert Gut Immunomodulatory Effects by Regulating the Expression of Host miRNAs. Probiotics and Antimicrobial Proteins 2025; 17(2) doi: 10.1007/s12602-024-10443-9
|
| 84 |
Juanjuan Wang, Wenyue Cheng, Rongcun Yang. Nervous system–gut microbiota–immune system axis: future directions for preventing tumor. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1535955
|
| 85 |
Michael A. Casasanta, Christopher C. Yoo, Barath Udayasuryan, Blake E. Sanders, Ariana Umaña, Yao Zhang, Huaiyao Peng, Alison J. Duncan, Yueying Wang, Liwu Li, Scott S. Verbridge, Daniel J. Slade.
Fusobacterium nucleatum
host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration
. Science Signaling 2020; 13(641) doi: 10.1126/scisignal.aba9157
|
| 86 |
Zixuan Li, Gang Chen, Panpan Wang, Minglei Sun, Junfang Zhao, Ang Li, Qiang Sun. Alterations of the Oral Microbiota Profiles in Chinese Patient With Oral Cancer. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.780067
|
| 87 |
Kai Ding, Pei Mou, Zhe Wang, Shuqing Liu, JinPei Liu, Hao Lu, Ganjun Yu. The next bastion to be conquered in immunotherapy: microsatellite stable colorectal cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1298524
|
| 88 |
Leonardo A. Guevarra, Andrea Claudine F. Afable, Patricia Joyce O. Belza, Karen Joy S. Dy, Scott Justin Q. Lee, Teresa T. Sy-Ortin, Pia Marie S. P. Albano. Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer. Infectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0184-7
|
| 89 |
Michelle Hanus, Daniela Parada-Venegas, Glauben Landskron, Ana Maria Wielandt, Claudia Hurtado, Karin Alvarez, Marcela A. Hermoso, Francisco López-Köstner, Marjorie De la Fuente. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.612826
|
| 90 |
Rodolfo Mauceri, Martina Coppini, Davide Vacca, Giorgio Bertolazzi, Valeria Cancila, Claudio Tripodo, Giuseppina Campisi. No Clear Clustering Dysbiosis from Salivary Microbiota Analysis by Long Sequencing Reads in Patients Affected by Oral Squamous Cell Carcinoma: A Single Center Study. Cancers 2023; 15(17) doi: 10.3390/cancers15174211
|
| 91 |
Xiaokun chen, Xiao Liu, Jie Gong, Shunda Du. The pro-metastatic role of microbiota in tumors: a comprehensive review. Cancer Cell International 2026; 26(1) doi: 10.1186/s12935-026-04390-4
|
| 92 |
Inés Mármol, Cristina Sánchez-de-Diego, Alberto Pradilla Dieste, Elena Cerrada, María Rodriguez Yoldi. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. International Journal of Molecular Sciences 2017; 18(1) doi: 10.3390/ijms18010197
|
| 93 |
Zahra Mojtahedi, Somayeh Rezaeifard, Zahra Faghih. Permissive/Protective Interplay of Microbiota with T Cell Adaptive Immune Response in Colon Cancer. Annals of Colorectal Research 2016; 4(4) doi: 10.17795/acr-43883
|
| 94 |
Pamela Pignatelli, Lorena Iezzi, Martina Pennese, Paolo Raimondi, Anna Cichella, Danilo Bondi, Rossella Grande, Roberto Cotellese, Nicola Di Bartolomeo, Paolo Innocenti, Adriano Piattelli, Maria Cristina Curia. The Potential of Colonic Tumor Tissue Fusobacterium nucleatum to Predict Staging and Its Interplay with Oral Abundance in Colon Cancer Patients. Cancers 2021; 13(5) doi: 10.3390/cancers13051032
|
| 95 |
Walaa K. Mousa, Fadia Chehadeh, Shannon Husband. Microbial dysbiosis in the gut drives systemic autoimmune diseases. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.906258
|
| 96 |
Daria Baholet, Sylvie Skalickova, Andrej Batik, Svetlana Malyugina, Jiri Skladanka, Pavel Horky. Importance of Zinc Nanoparticles for the Intestinal Microbiome of Weaned Piglets. Frontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.852085
|
| 97 |
Roxana Loriana Negrut, Adrian Cote, Adrian Marius Maghiar. Exploring the Potential of Oral Microbiome Biomarkers for Colorectal Cancer Diagnosis and Prognosis: A Systematic Review. Microorganisms 2023; 11(6) doi: 10.3390/microorganisms11061586
|
| 98 |
Kenichi Kumagai, Shigeo Ishikawa, Mitsuyoshi Iino, Kaoru Edamatsu, Naoki Okuyama, Kazuyuki Yusa, Yudai Shimizu, Reo Aoki, Chieko Masuda, Yoshihiro Ohashi, Akihisa Horie, Kazuto Hoshi, Yoshiki Hamada. Characterization of Salivary Microbiota in Japanese Patients with Oral Cancer. International Journal of Molecular Sciences 2025; 26(5) doi: 10.3390/ijms26052339
|
| 99 |
Masoud Arabfard, Mina Ohadi, Vahid Rezaei Tabar, Ahmad Delbari, Kaveh Kavousi. Genome-wide prediction and prioritization of human aging genes by data fusion: a machine learning approach. BMC Genomics 2019; 20(1) doi: 10.1186/s12864-019-6140-0
|
| 100 |
Raghad Khalid AL-Ishaq, Lenka Koklesova, Peter Kubatka, Dietrich Büsselberg. Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer. Cancers 2022; 14(9) doi: 10.3390/cancers14092140
|
| 101 |
S. Shamekhi, H. Lotfi, J. Abdolalizadeh, E. Bonabi, N. Zarghami. An overview of yeast probiotics as cancer biotherapeutics: possible clinical application in colorectal cancer. Clinical and Translational Oncology 2020; 22(8) doi: 10.1007/s12094-019-02270-0
|
| 102 |
Alireza Tojjari, Hassan Abushukair, Anwaar Saeed. The Crosstalk between Microbiome and Immunotherapeutics: Myth or Reality. Cancers 2022; 14(19) doi: 10.3390/cancers14194641
|
| 103 |
Minoru Koi, John M Carethers. The colorectal cancer immune microenvironment and approach to immunotherapies. Future Oncology 2017; 13(18) doi: 10.2217/fon-2017-0145
|
| 104 |
. 2020; doi: 10.70675/a8edc987z9f3az48d8z92ddzfb2a310ee4dd
|
| 105 |
H. Cuellar-Gómez, M.E. Ocharán-Hernández, C.C. Calzada-Mendoza, D.A. Comoto-Santacruz. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. Revista de Gastroenterología de México (English Edition) 2022; 87(3) doi: 10.1016/j.rgmxen.2021.07.001
|
| 106 |
Maria Graziela Kenupp, Alberto Vianna, Mari Uyeda, Gabriel Maluf. Patients with Colorectal Cancer . International Healthcare Review (online) 2024; doi: 10.56226/83
|
| 107 |
Ana María Wielandt, Claudia Hurtado, Mauricio Moreno C, Cynthia Villarroel, Magdalena Castro, Marlene Estay, Daniela Simian, Maripaz Martinez, Maria Teresa Vial, Udo Kronberg, Francisco López-Köstner. Characterization of Chilean patients with sporadic colorectal cancer according to the three main carcinogenic pathways: Microsatellite instability, CpG island methylator phenotype and Chromosomal instability. Tumor Biology 2020; 42(7) doi: 10.1177/1010428320938492
|
| 108 |
Ahamed A Khalyfa, Shil Punatar, Rida Aslam, Alex Yarbrough. Exploring the Inflammatory Pathogenesis of Colorectal Cancer. Diseases 2021; 9(4) doi: 10.3390/diseases9040079
|
| 109 |
Alexander A. Chumanevich, James R. Hébert, Malory Spicer, Lorne J. Hofseth. Diet, Inflammation, and Health. 2022; doi: 10.1016/B978-0-12-822130-3.00016-8
|
| 110 |
Tanushree Mondal, Deepanjan Chattopadhyay, Paromita Saha Mondal, Sanjib Das, Amalesh Mondal, Abhishek Das, Subhasree Samanta, Tanima Saha. Fusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development. International Journal of Biological Macromolecules 2025; 299 doi: 10.1016/j.ijbiomac.2025.140196
|
| 111 |
Martina King, Hermione Hurley, Kevin R. Davidson, Edward C. Dempsey, Michelle A. Barron, Edward D. Chan, Amy Frey. The Link between Fusobacteria and Colon Cancer: a Fulminant Example and Review of the Evidence. Immune Network 2020; 20(4) doi: 10.4110/in.2020.20.e30
|
| 112 |
Se Ju Lee, Yae Jee Baek, Jin Nam Kim, Ki Hyun Lee, Eun Hwa Lee, Joon Sup Yeom, Jun Yong Choi, Nam Su Ku, Jin Young Ahn, Jung Ho Kim, Su Jin Jeong, Tze Shien Lo. Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogen. PLOS ONE 2022; 17(4) doi: 10.1371/journal.pone.0266610
|
| 113 |
Benoit J. Kunath, Charlotte De Rudder, Cedric C. Laczny, Elisabeth Letellier, Paul Wilmes. The oral–gut microbiome axis in health and disease. Nature Reviews Microbiology 2024; 22(12) doi: 10.1038/s41579-024-01075-5
|
| 114 |
Yongzhi Yang, Wenhao Weng, Junjie Peng, Leiming Hong, Lei Yang, Yuji Toiyama, Renyuan Gao, Minfeng Liu, Mingming Yin, Cheng Pan, Hao Li, Bomin Guo, Qingchao Zhu, Qing Wei, Mary-Pat Moyer, Ping Wang, Sanjun Cai, Ajay Goel, Huanlong Qin, Yanlei Ma. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor−κB, and Up-regulating Expression of MicroRNA-21. Gastroenterology 2017; 152(4) doi: 10.1053/j.gastro.2016.11.018
|
| 115 |
Gang Wang, Yang Yu, Yu‐Zhu Wang, Jun‐Jie Wang, Rui Guan, Yan Sun, Feng Shi, Jing Gao, Xing‐Li Fu. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy. Journal of Cellular Physiology 2019; 234(10) doi: 10.1002/jcp.28436
|
| 116 |
Yang Yang, Gang Chen, Qian Yang, Juan Ye, Xueting Cai, Pamo Tsering, Xiaolan Cheng, Chunping Hu, Shuangquan Zhang, Peng Cao. Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction. Oncotarget 2017; 8(30) doi: 10.18632/oncotarget.16458
|
| 117 |
S. O. Kochkina, S. S. Gordeev, Z. Z. Mamedli. Role of human microbiota in the development of colorectal cancer. Surgery and Oncology 2019; 9(3) doi: 10.17650/2686-9594-2019-9-3-11-17
|
| 118 |
Yasuharu Takahashi, Jonguk Park, Koji Hosomi, Tomonori Yamada, Ayaka Kobayashi, Yuji Yamaguchi, Susumu Iketani, Jun Kunisawa, Kenji Mizuguchi, Nobuko Maeda, Tomoko Ohshima. Analysis of oral microbiota in Japanese oral cancer patients using 16S rRNA sequencing. Journal of Oral Biosciences 2019; 61(2) doi: 10.1016/j.job.2019.03.003
|
| 119 |
Janani Vigneswaran, Benjamin D. Shogan. The Role of the Intestinal Microbiome on Colorectal Cancer Pathogenesis and its Recurrence Following Surgery. Journal of Gastrointestinal Surgery 2020; 24(10) doi: 10.1007/s11605-020-04694-4
|
| 120 |
Harrisham Kaur, Chandrani Das, Sharmila S. Mande. In Silico Analysis of Putrefaction Pathways in Bacteria and Its Implication in Colorectal Cancer. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.02166
|
| 121 |
Dervla Kelly, Liying Yang, Zhiheng Pei. Gut Microbiota, Fusobacteria, and Colorectal Cancer. Diseases 2018; 6(4) doi: 10.3390/diseases6040109
|
| 122 |
Dae-Won Lee, Sae-Won Han, Jun-Kyu Kang, Jeong Mo Bae, Hwang-Phill Kim, Jae-Kyung Won, Seung-Yong Jeong, Kyu Joo Park, Gyeong Hoon Kang, Tae-You Kim. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer. Annals of Surgical Oncology 2018; 25(11) doi: 10.1245/s10434-018-6681-5
|
| 123 |
Xianzhe Yu, Lingling Zhu, Jiewei Liu, Ming Xie, Jiang Chen, Jianguo Li. <p>Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis</p>. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S271955
|
| 124 |
Jia Xuan Kee, Jia Ning Nicolette Yau, Ram Pravin Kumar Muthuramalingam, Xinyi Wang, Wei Heng Chng, Alvaro Lopez-Sanchez, Kevin Kuang Wei Tay, Lih-Wen Deng, Dan Gibson, Helene C. Bertrand, Giulia Adriani, Wee Han Ang, Giorgia Pastorin. Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs. Chemical Reviews 2025; 125(21) doi: 10.1021/acs.chemrev.5c00041
|
| 125 |
Ruihua Wang, Mei Chen, Xiaojun Ye, Karen Poon. Role and potential clinical utility of ARID1A in gastrointestinal malignancy. Mutation Research/Reviews in Mutation Research 2021; 787 doi: 10.1016/j.mrrev.2020.108360
|
| 126 |
Akhil Kapoor, Rohit Kumar, Anuj Gupta, Bipinesh Sansar, Bal Krishna Mishra, Mahesh Chaudhary, Archi Rungta, Gopalakrishna Kallapura, Kumar Prabhash. The microbiome and its impact on the epigenome in cancer. Frontiers in Epigenetics and Epigenomics 2026; 4 doi: 10.3389/freae.2026.1857307
|
| 127 |
Maria Carolina S Mendes, Daiane SM Paulino, Sandra R Brambilla, Juliana A Camargo, Gabriela F Persinoti, José Barreto C Carvalheira. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice. World Journal of Gastroenterology 2018; 24(18): 1995-2008 doi: 10.3748/wjg.v24.i18.1995
|
| 128 |
Shinya Kageyama, Yuka Nagao, Jiale Ma, Mikari Asakawa, Ryoji Yoshida, Toru Takeshita, Akiyuki Hirosue, Yoshihisa Yamashita, Hideki Nakayama. Compositional Shift of Oral Microbiota Following Surgical Resection of Tongue Cancer. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.600884
|
| 129 |
Shinya Kageyama, Toru Takeshita, Kenji Takeuchi, Mikari Asakawa, Rie Matsumi, Michiko Furuta, Yukie Shibata, Kiyoshi Nagai, Masahiko Ikebe, Masaru Morita, Muneyuki Masuda, Yasushi Toh, Yutaka Kiyohara, Toshiharu Ninomiya, Yoshihisa Yamashita. Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01780
|
| 130 |
Marufa Rumman, Misako Nagasaka, Bayan Al-Share, Asfar S. Azmi, Md. Hafiz Uddin. Microbiome, Immunity, Digestive Health and Nutrition. 2022; doi: 10.1016/B978-0-12-822238-6.00005-4
|
| 131 |
Brett S. Younginger, Oleg Mayba, Jens Reeder, Deepti R. Nagarkar, Zora Modrusan, Matthew L. Albert, Allyson L. Byrd. Enrichment of oral-derived bacteria in inflamed colorectal tumors and distinct associations of Fusobacterium in the mesenchymal subtype. Cell Reports Medicine 2023; 4(2) doi: 10.1016/j.xcrm.2023.100920
|
| 132 |
Ana Carolina de Carvalho, Leandro de Mattos Pereira, José Guilherme Datorre, Wellington dos Santos, Gustavo Noriz Berardinelli, Marcus de Medeiros Matsushita, Marco Antonio Oliveira, Ronilson Oliveira Durães, Denise Peixoto Guimarães, Rui Manuel Reis. Microbiota Profile and Impact of Fusobacterium nucleatum in Colorectal Cancer Patients of Barretos Cancer Hospital. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00813
|
| 133 |
Julio Plaza-Diaz, Marco Brandimonte-Hernández, Bricia López-Plaza, Francisco Javier Ruiz-Ojeda, Ana Isabel Álvarez-Mercado, Lucía Arcos-Castellanos, Jaime Feliú-Batlle, Thomas Hummel, Samara Palma-Milla, Angel Gil. Effect of a Novel Food Rich in Miraculin on the Intestinal Microbiome of Malnourished Patients with Cancer and Dysgeusia. Nutrients 2025; 17(2) doi: 10.3390/nu17020246
|
| 134 |
Bolun Zhou, Yutong Yuan, Shanshan Zhang, Can Guo, Xiaoling Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00575
|
| 135 |
Tsuyoshi Hamada, Jonathan A Nowak, Danny A Milner, Mingyang Song, Shuji Ogino. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome‐driven neoplasms. The Journal of Pathology 2019; 247(5) doi: 10.1002/path.5236
|
| 136 |
Changsheng Xing, Yang Du, Tianhao Duan, Kelly Nim, Junjun Chu, Helen Y. Wang, Rong-Fu Wang. Interaction between microbiota and immunity and its implication in colorectal cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.963819
|
| 137 |
Todd R Anderson, Emily Carletto, Valeria Barreto-Nadal, Emily Langston, Michael Jones. Intersecting Pathologies: Vulvar Cancer Complicated by a Fusobacterium necrophorum Infection. Cureus 2024; doi: 10.7759/cureus.73420
|
| 138 |
Amani M. Harrandah. The role of Fusobacteria in oral cancer and immune evasion. Current Opinion in Oncology 2023; 35(2) doi: 10.1097/CCO.0000000000000927
|
| 139 |
José Guilherme Datorre, Ana Carolina de Carvalho, Mariana Bisarro dos Reis, Monise dos Reis, Marcus Matsushita, Florinda Santos, Denise Peixoto Guimarães, Rui Manuel Reis. Accuracy and Clinical Relevance of Intra-Tumoral Fusobacterium nucleatum Detection in Formalin-Fixed Paraffin-Embedded (FFPE) Tissue by Droplet Digital PCR (ddPCR) in Colorectal Cancer. Diagnostics 2022; 12(1) doi: 10.3390/diagnostics12010114
|
| 140 |
Xusheng Zhang, Dou Yu, Di Wu, Xintong Gao, Fei Shao, Min Zhao, Jiang Wang, Jiangwen Ma, Wenzhao Wang, Xiwen Qin, Yi Chen, Pengyan Xia, Shuo Wang. Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance. Cell Host & Microbe 2023; 31(3) doi: 10.1016/j.chom.2023.01.013
|
| 141 |
Manuel Adrian Riveros Escalona, Joice de Faria Poloni, Mathias J Krause, Márcio Dorn. Meta-analyses of host metagenomes from colorectal cancer patients reveal strong relationship between colorectal cancer-associated species. Molecular Omics 2023; 19(5) doi: 10.1039/D3MO00021D
|
| 142 |
Brianna N. Maslen, Brad C. Hine, Christian Duff, Pamela A. Alexandre, Sam A. Clark, Julius van der Werf, Jason D. White, Sameer D. Pant. Faecal microbial profiles of Angus beef cattle with divergent immune responses. Livestock Science 2025; 297 doi: 10.1016/j.livsci.2025.105719
|
| 143 |
Cindy Neuzillet, Manon Marchais, Sophie Vacher, Marc Hilmi, Anne Schnitzler, Didier Meseure, Renaud Leclere, Charlotte Lecerf, Coraline Dubot, Emmanuelle Jeannot, Jerzy Klijanienko, Odette Mariani, Valentin Calugaru, Caroline Hoffmann, Maria Lesnik, Nathalie Badois, Edith Borcoman, Eliane Piaggio, Maud Kamal, Christophe Le Tourneau, Ivan Bieche. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86816-9
|
| 144 |
Valentina Artusa, Luana Calabrone, Lorenzo Mortara, Francesco Peri, Antonino Bruno. Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory. International Journal of Molecular Sciences 2023; 24(5) doi: 10.3390/ijms24054997
|
| 145 |
Tsuyoshi Hamada, Xuehong Zhang, Kosuke Mima, Susan Bullman, Yasutaka Sukawa, Jonathan A. Nowak, Keisuke Kosumi, Yohei Masugi, Tyler S. Twombly, Yin Cao, Mingyang Song, Li Liu, Annacarolina da Silva, Yan Shi, Mancang Gu, Wanwan Li, Hideo Koh, Katsuhiko Nosho, Kentaro Inamura, NaNa Keum, Kana Wu, Jeffrey A. Meyerhardt, Aleksandar D. Kostic, Curtis Huttenhower, Wendy S. Garrett, Matthew Meyerson, Edward L. Giovannucci, Andrew T. Chan, Charles S. Fuchs, Reiko Nishihara, Marios Giannakis, Shuji Ogino.
Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunology Research 2018; 6(11) doi: 10.1158/2326-6066.CIR-18-0174
|
| 146 |
Yuki Sakamoto, Kosuke Mima, Takatsugu Ishimoto, Yoko Ogata, Katsunori Imai, Yuji Miyamoto, Takahiko Akiyama, Nobuya Daitoku, Yukiharu Hiyoshi, Masaaki Iwatsuki, Yoshifumi Baba, Shiro Iwagami, Yo‐ichi Yamashita, Naoya Yoshida, Yoshihiro Komohara, Shuji Ogino, Hideo Baba. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis. Cancer Science 2021; 112(11) doi: 10.1111/cas.15126
|
| 147 |
Tomoyuki Ono, Tatsuro Yamaguchi, Misato Takao, Ekumi Kojika, Takeru Iijima, Shin-ichiro Horiguchi. Fusobacterium nucleatum load in MSI colorectal cancer subtypes. International Journal of Clinical Oncology 2022; 27(10) doi: 10.1007/s10147-022-02218-5
|
| 148 |
Liuyang Zhao, Xiang Zhang, Tao Zuo, Jun Yu. The Composition of Colonic Commensal Bacteria According to Anatomical Localization in Colorectal Cancer. Engineering 2017; 3(1) doi: 10.1016/J.ENG.2017.01.012
|
| 149 |
Baijun Zhou, Jiayun Lu, James D. Beck, Kevin L. Moss, Anna E. Prizment, Ryan T. Demmer, Kori A. Porosnicu Rodriguez, Corinne E. Joshu, Dominique S. Michaud, Elizabeth A. Platz. Periodontal and Other Oral Bacteria and Risk of Lung Cancer in the Atherosclerosis Risk in Communities (ARIC) Study. Cancer Epidemiology, Biomarkers & Prevention 2023; 32(4) doi: 10.1158/1055-9965.EPI-22-0601
|
| 150 |
Yuxuan Liang, Qingrong Zhang, Jing Yu, Wenyan Hu, Sihua Xu, Yiyuan Xiao, Hui Ding, Jiaming Zhou, Haitao Chen. Tumour-associated and non-tumour-associated bacteria co-abundance groups in colorectal cancer. BMC Microbiology 2024; 24(1) doi: 10.1186/s12866-024-03402-5
|
| 151 |
Poulami Sarkar, Somasri Shannigrahi, Olivia Sen, Subrata Adak, Priyanka Jana, Sreejan Manna. Gut Microbiome Modulation for Colorectal Cancer Therapy: Biomolecule‐Integrated Nanotherapeutic Strategies. ChemistrySelect 2026; 11(32) doi: 10.1002/slct.202507043
|
| 152 |
Violaine Randrian, Camille Evrard, David Tougeron. Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies. Cancers 2021; 13(12) doi: 10.3390/cancers13123063
|
| 153 |
Miriam Y. Walker, Siddharth Pratap, Janet H. Southerland, Cherae M. Farmer-Dixon, Kesavalu Lakshmyya, Pandu R. Gangula. Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide 2018; 73 doi: 10.1016/j.niox.2017.06.003
|
| 154 |
H. Cuellar-Gómez, M.E. Ocharán-Hernández, C.C. Calzada-Mendoza, D.A. Comoto-Santacruz. Asociación entre infección por Fusobacterium nucleatum y cáncer colorrectal: un estudio mexicano. Revista de Gastroenterología de México 2022; 87(3) doi: 10.1016/j.rgmx.2020.12.002
|
| 155 |
Shashanka K. Prasad, Smitha Bhat, Dharini Shashank, Akshatha C. R., Sindhu R., Pornchai Rachtanapun, Devananda Devegowda, Prasanna K. Santhekadur, Sarana Rose Sommano. Bacteria-Mediated Oncogenesis and the Underlying Molecular Intricacies: What We Know So Far. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.836004
|
| 156 |
Chao Zhang, Sarah Ellen Powell, Doron Betel, Manish A. Shah. The Gastric Microbiome and Its Influence on Gastric Carcinogenesis. Hematology/Oncology Clinics of North America 2017; 31(3) doi: 10.1016/j.hoc.2017.01.002
|
| 157 |
Guiqiu Li, Yan Sun, Yu Huang, Jie Lian, Shaoyuan Wu, Dixian Luo, Hui Gong. Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10844-z
|
| 158 |
Marina A Senchukova. Genetic heterogeneity of colorectal cancer and the microbiome. World Journal of Gastrointestinal Oncology 2023; 15(3): 443-463 doi: 10.4251/wjgo.v15.i3.443
|
| 159 |
Nutta Iadsee, Natthaya Chuaypen, Teerasit Techawiwattanaboon, Thananya Jinato, Tanisa Patcharatrakul, Songphol Malakorn, Aisawan Petchlorlian, Kearkiat Praditpornsilpa, Kanitha Patarakul. Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33794-9
|
| 160 |
Xiangxiang Xu, Meng Zhang, Xiaoyan Liu, Mingze Chai, Lu Diao, Lin Ma, Shuang Nie, Minghao Xu, Yipeng Wang, Fengfeng Mo, Mi Liu. Probiotics formulation and cancer nanovaccines show synergistic effect in immunotherapy and prevention of colon cancer. iScience 2023; 26(7) doi: 10.1016/j.isci.2023.107167
|
| 161 |
Reza Torkashvand, Bahareh Hajikhani, Masoud Dadashi, Hossein Dabiri, Reza Hosseini Doust. The Correlation Between Fusobacterium nucleatum and Colorectal Cancer: A Comprehensive Review. International Journal of Enteric Pathogens 2024; 12(3) doi: 10.34172/ijep.5672
|
| 162 |
Concetta Panebianco, Adele Potenza, Angelo Andriulli, Valerio Pazienza. Exploring the microbiota to better understand gastrointestinal cancers physiology. Clinical Chemistry and Laboratory Medicine (CCLM) 2018; 56(9) doi: 10.1515/cclm-2017-1163
|
| 163 |
Poshita Kumari Seesaha, Xiaofeng Chen, Xiaofeng Wu, Hongxia Xu, Changxian Li, Yogesh Jheengut, Fengjiao Zhao, Li Liu, Diancai Zhang. The interplay between dietary factors, gut microbiome and colorectal cancer: a new era of colorectal cancer prevention. Future Oncology 2020; 16(7) doi: 10.2217/fon-2019-0552
|
| 164 |
Chun Ye, Xiao Liu, Zilun Liu, Chuxuan Pan, Xiaowei Zhang, Zhanyi Zhao, Haitao Sun. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance. Cancer Biology & Therapy 2024; 25(1) doi: 10.1080/15384047.2024.2306676
|
| 165 |
G. G. Khakimova, A. A. Tryakin, T. N. Zabotina, A. S. Tsukanov, V. A. Aliev, S. L. Gutorov. The Role of the Intestinal Microbiome in the Immunotherapy of Colon Cancer. Malignant tumours 2019; 9(2) doi: 10.18027/2224-5057-2019-9-2-5-11
|
| 166 |
Ke-Tao Jin, Bo Chen, Yu-Yao Liu, H uan-Rong Lan, Jie-Ping Yan. Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01763-9
|
| 167 |
Laura Paleari. Cancer Prevention with Molecular Targeted Therapies. International Journal of Molecular Sciences 2022; 23(15) doi: 10.3390/ijms23158429
|
| 168 |
Nataliia Nikolaieva, Aneta Sevcikova, Radoslav Omelka, Monika Martiniakova, Michal Mego, Sona Ciernikova. Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development. Microorganisms 2022; 11(1) doi: 10.3390/microorganisms11010107
|
| 169 |
Herbert Tilg, Timon E. Adolph, Romana R. Gerner, Alexander R. Moschen. The Intestinal Microbiota in Colorectal Cancer. Cancer Cell 2018; 33(6) doi: 10.1016/j.ccell.2018.03.004
|
| 170 |
Xing Kang, Ru Zhang, Thomas Ny Kwong, Rashid Ns Lui, William Kk Wu, Joseph Jy Sung, Jun Yu, Sunny H Wong. Serrated neoplasia in the colorectum: gut microbiota and molecular pathways. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2020.1863135
|
| 171 |
Siyang Xu, Wen Yin, Yuling Zhang, Qimei Lv, Yijun Yang, Jin He. Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer. Cancers 2020; 12(2) doi: 10.3390/cancers12020372
|
| 172 |
Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, Shuji Ogino, John D. Potter, Polly A. Newcomb, Amanda I. Phipps. Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors. Cancer Epidemiology, Biomarkers & Prevention 2025; 34(8) doi: 10.1158/1055-9965.EPI-24-1020
|
| 173 |
Jin Yan, Ruixia Ma, Yaguang Xi. MicroRNAs in Colorectal Cancer Immunotherapy: Biomarkers, Resistance Mechanisms, and Strategies to Convert “Cold” Tumors to “Hot”. Genes 2026; 17(9) doi: 10.3390/genes17091025
|
| 174 |
Mengjie Luo. Fusobacterium nucleatum: a novel regulator of antitumor immune checkpoint blockade therapy in colorectal cancer. American Journal of Cancer Research 2024; 14(8) doi: 10.62347/MYZA2640
|
| 175 |
Eugeniy P. Smorodin. Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer. International Journal of Molecular Sciences 2021; 22(21) doi: 10.3390/ijms222111608
|
| 176 |
Implication of gut microbes and its metabolites in colorectal cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(1) doi: 10.1007/s00432-022-04422-2
|
| 177 |
Amanda I. Phipps, Courtney M. Hill, Genevieve Lin, Rachel C. Malen, Adriana M. Reedy, Orsalem Kahsai, Hamza Ammar, Keith Curtis, Ningxin Ma, Timothy W. Randolph, Jing Ma, Shuji Ogino, Polly A. Newcomb, Meredith AJ. Hullar. Fusobacterium nucleatum Enrichment in Colorectal Tumor Tissue: Associations With Tumor Characteristics and Survival Outcomes. Gastro Hep Advances 2025; 4(6) doi: 10.1016/j.gastha.2025.100644
|
| 178 |
Yeon Ji Kim, Bu Kyung Kim, Seun Ja Park, Jae Hyun Kim. Impact of <i>Fusobacterium nucleatum</i> in the gastrointestinal tract on natural killer cells. World Journal of Gastroenterology 2021; 27(29): 4879-4889 doi: 10.3748/wjg.v27.i29.4879
|
| 179 |
Haohong Zhang, Xinghao Xiong, Mingyue Cheng, Lei Ji, Kang Ning, Jack A. Gilbert. Deep learning enabled integration of tumor microenvironment microbial profiles and host gene expressions for interpretable survival subtyping in diverse types of cancers. mSystems 2024; 9(12) doi: 10.1128/msystems.01395-24
|
| 180 |
Yi Wang, Yuting Wen, Jiayin Wang, Xin Lai, Ying Xu, Xuanping Zhang, Xiaoyan Zhu, Chenglin Ruan, Yao Huang. Clinicopathological differences of high Fusobacterium nucleatum levels in colorectal cancer: A review and meta-analysis. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.945463
|
| 181 |
Amer H. Asseri, Tahani Bakhsh, Samah Sulaiman Abuzahrah, Sajad Ali, Irfan A. Rather. The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1208044
|
| 182 |
Yumi Shimomura, Yutaka Sugi, Aiko Kume, Wataru Tanaka, Tsutomu Yoshihara, Tetsuya Matsuura, Yasuhiko Komiya, Yusuke Ogata, Wataru Suda, Masahira Hattori, Takuma Higurashi, Atsushi Nakajima, Mitsuharu Matsumoto, Olga Soutourina, Emma Allen-Vercoe.
Strain-level detection of
Fusobacterium nucleatum
in colorectal cancer specimens by targeting the CRISPR–Cas region
. Microbiology Spectrum 2023; 11(6) doi: 10.1128/spectrum.05123-22
|
| 183 |
Kosuke Mima, Yin Cao, Andrew T Chan, Zhi Rong Qian, Jonathan A Nowak, Yohei Masugi, Yan Shi, Mingyang Song, Annacarolina da Silva, Mancang Gu, Wanwan Li, Tsuyoshi Hamada, Keisuke Kosumi, Akiko Hanyuda, Li Liu, Aleksandar D Kostic, Marios Giannakis, Susan Bullman, Caitlin A Brennan, Danny A Milner, Hideo Baba, Levi A Garraway, Jeffrey A Meyerhardt, Wendy S Garrett, Curtis Huttenhower, Matthew Meyerson, Edward L Giovannucci, Charles S Fuchs, Reiko Nishihara, Shuji Ogino. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clinical and Translational Gastroenterology 2016; 7(11) doi: 10.1038/ctg.2016.53
|
| 184 |
Meenakshi Rajpoot, Anil K. Sharma, Anil Sharma, Girish Kumar Gupta. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer. Seminars in Cancer Biology 2018; 52 doi: 10.1016/j.semcancer.2018.02.003
|
| 185 |
Gaia Sambruni, Angeli D. Macandog, Jakob Wirbel, Danilo Cagnina, Carlotta Catozzi, Tiziano Dallavilla, Francesca Borgo, Nicola Fazio, Uberto Fumagalli-Romario, Wanda L. Petz, Teresa Manzo, Simona P. Ravenda, Georg Zeller, Luigi Nezi, Martin H. Schaefer. Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data. Genome Medicine 2023; 15(1) doi: 10.1186/s13073-023-01180-9
|
| 186 |
Huixia Chen, Hui Xie, Dong Shao, Liju Chen, Siyu Chen, Lin Wang, Xiao Han. Oral Microbiota, a Potential Determinant for the Treatment Efficacy of Gastric Helicobacter pylori Eradication in Humans. Polish Journal of Microbiology 2022; 71(2) doi: 10.33073/pjm-2022-020
|
| 187 |
Dominik Ternes, Jessica Karta, Mina Tsenkova, Paul Wilmes, Serge Haan, Elisabeth Letellier. Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism?. Trends in Microbiology 2020; 28(5) doi: 10.1016/j.tim.2020.01.001
|
| 188 |
Le Li, Vidhi Chandra, Florencia McAllister. Tumor-resident microbes: the new kids on the microenvironment block. Trends in Cancer 2024; 10(4) doi: 10.1016/j.trecan.2023.12.002
|
| 189 |
Sasi S. Senga, Richard P. Grose. Hallmarks of cancer—the new testament. Open Biology 2021; 11(1) doi: 10.1098/rsob.200358
|
| 190 |
Francesco DI PIERRO, Alexander BERTUCCIOLI, Massimiliano CAZZANIGA, Mariarosaria MATERA, Ilaria CAVECCHIA, Viviana GERARDI, Stefania PICCIRELLI, Daniele SALVI, Cecilia L. PUGLIANO, Paola CESARO, Cristiano SPADA, Luigina GUASTI, Nicola ZERBINATI. Can microbiota analysis help intercept cases of colon cancer in case of occult blood negativity, also suggesting possible pharmacological intervention strategies?. Minerva Gastroenterology 2024; 70(1) doi: 10.23736/S2724-5985.23.03578-7
|
| 191 |
Li-Wei Wang, Hao Ruan, Bang-Mao Wang, Yuan Qin, Wei-Long Zhong. Microbiota regulation in constipation and colorectal cancer. World Journal of Gastrointestinal Oncology 2023; 15(5): 776-786 doi: 10.4251/wjgo.v15.i5.776
|
| 192 |
Xin Deng, Shaohong Huang. Microbiome-macrophage crosstalk in the tumor microenvironment: implications for oral squamous cell carcinoma progression and therapy. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1651837
|
| 193 |
Rachel V. Purcell, Martina Visnovska, Patrick J. Biggs, Sebastian Schmeier, Frank A. Frizelle. Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11237-6
|
| 194 |
Haibo Chang, Rajeev Mishra, Chaoping Cen, Yunqing Tang, Chenchen Ma, Sanjeev Wasti, Yuanyuan Wang, Qianying Ou, Kaining Chen, Jiachao Zhang. Metagenomic Analyses Expand Bacterial and Functional Profiling Biomarkers for Colorectal Cancer in a Hainan Cohort, China. Current Microbiology 2021; 78(2) doi: 10.1007/s00284-020-02299-3
|
| 195 |
Durre Aden, Kamlesh Darji, Sufian Zaheer. Cancer and the gut microbiome: the oncogenic impact of dysbiosis. Surgical and Experimental Pathology 2026; 9(1) doi: 10.1186/s42047-026-00244-5
|
| 196 |
Ivan Borozan, Syed H. Zaidi, Tabitha A. Harrison, Amanda I. Phipps, Jiayin Zheng, Stephen Lee, Quang M. Trinh, Robert S. Steinfelder, Jeremy Adams, Barbara L. Banbury, Sonja I. Berndt, Stefanie Brezina, Daniel D. Buchanan, Susan Bullman, Yin Cao, Alton B. Farris, Jane C. Figueiredo, Marios Giannakis, Lawrence E. Heisler, John L. Hopper, Yi Lin, Xuemei Luo, Reiko Nishihara, Elaine R. Mardis, Nickolas Papadopoulos, Conghui Qu, Emma E.G. Reid, Stephen N. Thibodeau, Sophia Harlid, Caroline Y. Um, Li Hsu, Andrea Gsur, Peter T. Campbell, Steven Gallinger, Polly A. Newcomb, Shuji Ogino, Wei Sun, Thomas J. Hudson, Vincent Ferretti, Ulrike Peters. Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis
. Cancer Epidemiology, Biomarkers & Prevention 2022; 31(1) doi: 10.1158/1055-9965.EPI-21-0463
|
| 197 |
Goro Takahashi, Akihisa Matsuda, Takeshi Yamada, Kay Uehara, Seiichi Shinji, Yasuyuki Yokoyama, Takuma Iwai, Toshimitsu Miyasaka, Shintaro Kanaka, Daigo Yoshimori, Takanori Matsui, Koki Hayashi, Hiroshi Yoshida. Immune Checkpoint Inhibitors for Microsatellite Instability High Unresectable Obstructive Colon Cancer: A Report of Two Cases. Surgical Case Reports 2025; 11(1) doi: 10.70352/scrj.cr.25-0070
|
| 198 |
Inge Huybrechts, Semi Zouiouich, Astrid Loobuyck, Zeger Vandenbulcke, Emily Vogtmann, Silvia Pisanu, Isabel Iguacel, Augustin Scalbert, Iciar Indave, Vitaly Smelov, Marc J. Gunter, Nathalie Michels. The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(10) doi: 10.1158/1055-9965.EPI-20-0288
|
| 199 |
Mahsa Khosrojerdi, Farahzad Jabbari Azad, Ali Haghbin, Amir Azimian. Gut microbiota and the immune system: A regulatory axis through host MicroRNA modulation. Infection, Genetics and Evolution 2026; 143 doi: 10.1016/j.meegid.2026.105996
|
| 200 |
Ana María Gómez García, Francisco López Muñoz, Eduardo García-Rico. The Microbiota in Cancer: A Secondary Player or a Protagonist?. Current Issues in Molecular Biology 2024; 46(8) doi: 10.3390/cimb46080463
|
| 201 |
Ziwei Zhou, Jiewen Chen, Herui Yao, Hai Hu. Fusobacterium and Colorectal Cancer. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00371
|
| 202 |
Yue Li, Xingyu Shen, Deqiang Wang, Kang Sun. The gut microbiome in colorectal cancer: mechanisms of carcinogenesis and emerging microbiota-targeted therapies. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-025-04367-1
|
| 203 |
Sameena Parveen, Ahmed Shaher Alqahtani, Mohammed Y. Aljabri, Tazeen Dawood, Samar Saeed Khan, Bharti Gupta, Swetha Vempalli, Ali Abdel-Halim Abdel-Azim Hassan, Nahid Mahmoud Hassan Elamin. Exploring the Interplay: Oral–Gut Microbiome Connection and the Impact of Diet and Nutrition. European Journal of General Dentistry 2024; 13(03) doi: 10.1055/s-0044-1786154
|
| 204 |
Hisham Hussan, Steven K Clinton, Kristen Roberts, Michael T Bailey. <i>Fusobacterium</i>’s link to colorectal neoplasia sequenced: A systematic review and future insights. World Journal of Gastroenterology 2017; 23(48): 8626-8650 doi: 10.3748/wjg.v23.i48.8626
|
| 205 |
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, Masaaki Iwatsuki, Yukiharu Hiyoshi, Yuji Miyamoto, Naoya Yoshida, Rong Wu, Hideo Baba. Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer. Journal of Gastroenterology 2019; 54(1) doi: 10.1007/s00535-018-1512-9
|
| 206 |
Kawther Zaher, Fatemah Basingab. Interaction between Gut Microbiota and Dendritic Cells in Colorectal Cancer. Biomedicines 2023; 11(12) doi: 10.3390/biomedicines11123196
|
| 207 |
Yan Chen, Ying-Xuan Chen. Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer. Cancers 2021; 13(16) doi: 10.3390/cancers13164054
|
| 208 |
Qiaoli Yang, Xiaoyu Huang, Shengguo Zhao, Wenyang Sun, Zunqiang Yan, Pengfei Wang, Shenggui Li, Wangzhou Huang, Shengwei Zhang, Lixia Liu, Shuangbao Gun. Structure and Function of the Fecal Microbiota in Diarrheic Neonatal Piglets. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.00502
|
| 209 |
Raaj S. Mehta, Reiko Nishihara, Yin Cao, Mingyang Song, Kosuke Mima, Zhi Rong Qian, Jonathan A. Nowak, Keisuke Kosumi, Tsuyoshi Hamada, Yohei Masugi, Susan Bullman, David A. Drew, Aleksandar D. Kostic, Teresa T. Fung, Wendy S. Garrett, Curtis Huttenhower, Kana Wu, Jeffrey A. Meyerhardt, Xuehong Zhang, Walter C. Willett, Edward L. Giovannucci, Charles S. Fuchs, Andrew T. Chan, Shuji Ogino. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue. JAMA Oncology 2017; 3(7) doi: 10.1001/jamaoncol.2016.6374
|
| 210 |
Tamar Alon‐Maimon, Ofer Mandelboim, Gilad Bachrach. Fusobacterium nucleatum and cancer. Periodontology 2000 2022; 89(1) doi: 10.1111/prd.12426
|
| 211 |
Javad Nezhadi, Hossein Samadi Kafil, Mohammad Sadrkabir, Farshad Mahdavi, Seyed Yaghoub Moaddab, Roghayeh Nouri, Yalda Mohammadzadeh-Asl, Simin Sattarpour, Mohammad Ahangarzadeh Rezaee. The relationship between pathogenic bacteria and different stages of colorectal cancer. Letters in Applied Microbiology 2025; 78(2) doi: 10.1093/lambio/ovaf017
|
| 212 |
Kangjia Luo, Yvkun Zhang, Chao Xv, Jingjing Ji, Ge Lou, Xiaorong Guo, Meilun Chen, Yingjie Zhang, Huiying Wei, Mian Guo, Rui Huang, Shan Yu. Fusobacterium nucleatum, the communication with colorectal cancer. Biomedicine & Pharmacotherapy 2019; 116 doi: 10.1016/j.biopha.2019.108988
|
| 213 |
Juliana Noguti, Alfred A. Chan, Bradley Bandera, Colin J. Brislawn, Mladjan Protic, Myung S. Sim, Janet K. Jansson, Anton J. Bilchik, Delphine J. Lee. Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial. Oncotarget 2018; 9(34) doi: 10.18632/oncotarget.25276
|
| 214 |
Li X, Han Y, Zhang A, Miao J, Sun H, Yan G, Wu F, Wang X. Mechanistic and Therapeutic Advances in Colon Cancer: A Systematic Review. Open Journal of Proteomics and Genomics 2019; doi: 10.17352/ojpg.000008
|
| 215 |
Jingbo Jiao, Ping Li, Ying Gu, Xinjun Du, Shuo Wang, Junping Wang. A fluorescence quenching-recovery sensor based on RCA for the specific analysis of Fusobacterium nucleatum. nucleatum. Analytical Biochemistry 2020; 604 doi: 10.1016/j.ab.2020.113808
|
| 216 |
Zexin Zhang, Wenfeng Wu, Zhikai Xiahou, Yafeng Song. Unveiling the hidden link between oral flora and colorectal cancer: a bidirectional Mendelian randomization analysis and meta-analysis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1451160
|
| 217 |
Run-Zhi Deng, Xin Zheng, Zhong-Lei Lu, Ming Yuan, Qi-Chang Meng, Tao Wu, Yu Tian. Effect of colorectal cancer stem cells on the development and metastasis of colorectal cancer. World Journal of Gastrointestinal Oncology 2024; 16(11): 4354-4368 doi: 10.4251/wjgo.v16.i11.4354
|
| 218 |
Yu-Jing Jiang, Nai-Ting Guo, Xue-Ping Xia, Yi Ji, Jie-Ge Huo. Immunotherapy strategies and traditional Chinese medicine treatment for microsatellite stable metastatic colorectal cancer. World Chinese Journal of Digestology 2023; 31(24) doi: 10.11569/wcjd.v31.i24.1007
|
| 219 |
Bi Wang, Bo Deng, Fan Yong, Huixia Zhou, Chunpu Qu, Zhengyan Zhou. Comparison of the fecal microbiomes of healthy and diarrheic captive wild boar. Microbial Pathogenesis 2020; 147 doi: 10.1016/j.micpath.2020.104377
|
| 220 |
Rajesh Kumar, Seetha Harilal, Simone Carradori, Bijo Mathew. A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century. Current Medicinal Chemistry 2021; 28(14) doi: 10.2174/0929867327666201026143757
|
| 221 |
Wen-dan Chen, Xin Zhang, Ya-ping Zhang, Cong-bo Yue, Yan-lei Wang, Hong-wei Pan, Yan-li Zhang, Hui Liu, Yi Zhang. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer. Current Medical Science 2022; 42(3) doi: 10.1007/s11596-022-2597-1
|
| 222 |
Kosuke Mima, Jonathan A. Nowak, Zhi Rong Qian, Yin Cao, Mingyang Song, Yohei Masugi, Yan Shi, Annacarolina da Silva, Mancang Gu, Wanwan Li, Tsuyoshi Hamada, Xuehong Zhang, Kana Wu, Jeffrey A. Meyerhardt, Hideo Baba, Edward L. Giovannucci, Andrew T. Chan, Charles S. Fuchs, Shuji Ogino, Reiko Nishihara. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival. Oncotarget 2016; 7(34) doi: 10.18632/oncotarget.10398
|
| 223 |
Lukas Niederreiter, Timon E. Adolph, Herbert Tilg. Food, microbiome and colorectal cancer. Digestive and Liver Disease 2018; 50(7) doi: 10.1016/j.dld.2018.03.030
|
| 224 |
Maryam Ranjbar, Rasoul Salehi, Shaghayegh Haghjooy Javanmard, Laleh Rafiee, Habibollah Faraji, Sima jafarpor, Gordon A. Ferns, Majid Ghayour-Mobarhan, Mostafa Manian, Reza Nedaeinia. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01886-z
|
| 225 |
Siyi Yu, Shuyi Wang, Bin Xiong, Chunwei Peng. Gut microbiota: key facilitator in metastasis of colorectal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1270991
|
| 226 |
Zixin Fan, Pengzhou Tang, Cheng Li, Qi Yang, Yan Xu, Chuan Su, Lu Li.
Fusobacterium nucleatum
and its associated systemic diseases: epidemiologic studies and possible mechanisms
. Journal of Oral Microbiology 2023; 15(1) doi: 10.1080/20002297.2022.2145729
|
| 227 |
Kimberly Hartl, Michael Sigal. Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis. International Journal of Molecular Sciences 2020; 21(20) doi: 10.3390/ijms21207439
|
| 228 |
Sapnita Shinde, Vibha Sinha, Vineeta Dixit, Mrigendra Dwivedi, Naveen Kumar Vishwakarma, Atul Kumar Tiwari, Sanjay Kumar Pandey, Dhananjay Shukla. Colon Cancer Diagnosis and Therapy. 2021; doi: 10.1007/978-3-030-64668-4_2
|
| 229 |
Quan Lin, Shi-Wei Guan, Hai-Bo Yu. Immuno-oncology-microbiome axis of gastrointestinal malignancy. World Journal of Gastrointestinal Oncology 2023; 15(5): 757-775 doi: 10.4251/wjgo.v15.i5.757
|
| 230 |
Koki Takeda, Minoru Koi, Yoshiki Okita, Sija Sajibu, Temitope O. Keku, John M. Carethers.
Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal Adenocarcinoma. Cancer Research Communications 2023; 3(9) doi: 10.1158/2767-9764.CRC-23-0179
|
| 231 |
Qiu-Luo Liu, Huijie Zhou, Ziqiang Wang, Yan Chen. Exploring the role of gut microbiota in colorectal liver metastasis through the gut-liver axis. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1563184
|
| 232 |
Zhenhua Yang, Guang Ji. Fusobacterium�nucleatum‑positive colorectal cancer (Review). Oncology Letters 2019; doi: 10.3892/ol.2019.10433
|
| 233 |
Qicheng Lu, Junli Niu, Yanyan Wu, Wenju Zhang. Effects of Saccharomyces cerevisiae var. boulardii on growth, incidence of diarrhea, serum immunoglobulins, and rectal microbiota of suckling dairy calves. Livestock Science 2022; 258 doi: 10.1016/j.livsci.2022.104875
|
| 234 |
Jing Li, Ai-hua Zhang, Fang-fang Wu, Xi-jun Wang. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.841552
|
| 235 |
Yixin Liu, Sheng Tian, Biao Ning, Tianhe Huang, Yi Li, Yongchang Wei. Stress and cancer: The mechanisms of immune dysregulation and management. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1032294
|
| 236 |
Yu-Pei Zhuang, Hong-Li Zhou, Hai-Bin Chen, Ming-Yue Zheng, Yu-Wei Liang, Yu-Tian Gu, Wen-Ting Li, Wen-Li Qiu, Hong-Guang Zhou. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application. Biomedicine & Pharmacotherapy 2023; 165 doi: 10.1016/j.biopha.2023.115040
|
| 237 |
José G. Datorre, Mariana B. dos Reis, Ana C. de Carvalho, Jun Porto, Gabriela H. Rodrigues, Adhara B. Lima, Monise T. Reis, Welinton Hirai, Claudio L. Hashimoto, Denise P. Guimarães, Rui M. Reis. Enhancing Colorectal Cancer Screening with Droplet Digital PCR Analysis of Fusobacterium nucleatum in Fecal Immunochemical Test Samples. Cancer Prevention Research 2024; 17(10) doi: 10.1158/1940-6207.CAPR-23-0331
|
| 238 |
Mary E. Booth, Henry M. Wood, Mark A. Travis, J. C. Ambrose, p. Arumugam, R. Bevers, M. Bleda, F. Boardman-Pretty, C. R. Boustred, H. Brittain, M. A. Brown, M. J. Caulfield, G. C. Chan, A. Giess, J. N. Griffin, A. Hamblin, S. Henderson, T. J. P. Hubbard, R. Jackson, L. J. Jones, D. Kasperaviciute, M. Kayikci, A. Kousathanas, L. Lahnstein, A. Lakey, S. E. A. Leigh, I. U. S. Leong, F. J. Lopez, F. Maleady-Crowe, M. McEntagart, F. Minneci, J. Mitchell, L. Moutsianas, M. Mueller, N. Murugaesu, A. C. Need, P. O‘Donovan, C. A. Odhams, C. Patch, D. Perez-Gil, M. B. Pereira, J. Pullinger, T. Rahim, A. Rendon, T. Rogers, K. Savage, K. Sawant, R. H. Scott, A. Siddiq, A. Sieghart, S. C. Smith, A. Sosinsky, A. Stuckey, M. Tanguy, A. L. Taylor Tavares, E. R. A. Thomas, S. R. Thompson, A. Tucci, M. J. Welland, E. Williams, K. Witkowska, S. M. Wood, M. Zarowiecki, Phil Quirke, Heike I. Grabsch. The relationship between the gastric cancer microbiome and clinicopathological factors: a metagenomic investigation from the 100,000 genomes project and The Cancer Genome Atlas. Gastric Cancer 2025; 28(3) doi: 10.1007/s10120-025-01588-9
|
| 239 |
Riley K. Wells, Amada Torres, Marjorie K. Mau, Alika K. Maunakea. Racial–Ethnic Disparities of Obesity Require Community Context-Specific Biomedical Research for Native Hawaiians and Other Pacific Islanders. Nutrients 2024; 16(24) doi: 10.3390/nu16244268
|
| 240 |
Yi-Wei Chen, Omri Kariv, Hung Ton-That. Fusobacterium nucleatum. Methods in Molecular Biology 2026; 3055 doi: 10.1007/978-1-0716-5388-3_14
|
| 241 |
Zhuangzhuang Zheng, Chenbin Bian, Huanhuan Wang, Jing Su, Lingbin Meng, Ying Xin, Xin Jiang. Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer. Therapeutic Advances in Medical Oncology 2022; 14 doi: 10.1177/17588359221138383
|
| 242 |
Hai-Fang Wang, Lin-Fang Li, Song-He Guo, Qiu-Yao Zeng, Fen Ning, Wan-Li Liu, Ge Zhang. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep33440
|
| 243 |
József Szabó, Gergely Maróti, Norbert Solymosi, Emese Andrásofszky, Tamás Tuboly, András Bersényi, Geza Bruckner, István Hullár. Fructose, glucose and fat interrelationships with metabolic pathway regulation and effects on the gut microbiota. Acta Veterinaria Hungarica 2021; 69(2) doi: 10.1556/004.2021.00022
|
| 244 |
Christine Shieh, Henry J. Thompson, Eric McLaughlin, Chien-Wei Chiang, Hisham Hussan. Advancements in Understanding and Preventing Obesity-Related Colon Cancer. The Cancer Journal 2024; 30(5) doi: 10.1097/PPO.0000000000000744
|
| 245 |
Kefan Bi, Xujun Zhang, Wenbiao Chen, Hongyan Diao. MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review. Genes 2020; 11(9) doi: 10.3390/genes11091075
|
| 246 |
Jiatian Chen, Jinting Zhao, Xiaoxiao Zhang, Huirong Zhu. Gut microbiota regulation and Traditional Chinese Medicine syndrome differentiation in right- and left-sided colon cancer heterogeneity — A review. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1768252
|
| 247 |
Mingyang Song, Andrew T. Chan, Jun Sun. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology 2020; 158(2) doi: 10.1053/j.gastro.2019.06.048
|
| 248 |
N. Kashani, A.T. Bezmin Abadi, F. Rahimi, M. Forootan. FadA-positive Fusobacterium nucleatum is prevalent in biopsy specimens of Iranian patients with colorectal cancer. New Microbes and New Infections 2020; 34 doi: 10.1016/j.nmni.2020.100651
|
| 249 |
Fanli Kong, Yi Cai. Study Insights into Gastrointestinal Cancer through the Gut Microbiota. BioMed Research International 2019; 2019 doi: 10.1155/2019/8721503
|
| 250 |
Denis Bourgeois, Camille Inquimbert, Livia Ottolenghi, Florence Carrouel. Periodontal Pathogens as Risk Factors of Cardiovascular Diseases, Diabetes, Rheumatoid Arthritis, Cancer, and Chronic Obstructive Pulmonary Disease—Is There Cause for Consideration?. Microorganisms 2019; 7(10) doi: 10.3390/microorganisms7100424
|
| 251 |
Shivtaj Mann, Manreet Sidhu, Krisstina Gowin. Understanding the Mechanisms of Diet and Outcomes in Colon, Prostate, and Breast Cancer; Malignant Gliomas; and Cancer Patients on Immunotherapy. Nutrients 2020; 12(8) doi: 10.3390/nu12082226
|
| 252 |
Linyuan Cao, Zhemin Liu, Ying Yu, Qingping Liang, Xinyi Wei, Han Sun, Yangtao Fang, Changliang Zhu, Qing Kong, Xiaodan Fu, Haijin Mou. Butyrogenic effect of galactosyl and mannosyl carbohydrates and their regulation on piglet intestinal microbiota. Applied Microbiology and Biotechnology 2023; 107(5-6) doi: 10.1007/s00253-023-12436-0
|
| 253 |
William P. Duggan, Manuela Salvucci, Batuhan Kisakol, Andreas U. Lindner, Ian S. Reynolds, Heiko Dussmann, Joanna Fay, Tony O’Grady, Daniel B. Longley, Fiona Ginty, Elizabeth Mc Donough, Daniel J. Slade, John P. Burke, Jochen H. M. Prehn. Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome. Journal of Molecular Medicine 2023; 101(7) doi: 10.1007/s00109-023-02324-5
|
| 254 |
Sally Temraz, Farah Nassar, Rihab Nasr, Maya Charafeddine, Deborah Mukherji, Ali Shamseddine. Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174155
|
| 255 |
Alberto Martin, Thergiory Irrazábal. Reference Module in Biomedical Sciences. 2018; doi: 10.1016/B978-0-12-801238-3.65124-3
|
| 256 |
Kannan Thanikachalam, Gazala Khan. Colorectal Cancer and Nutrition. Nutrients 2019; 11(1) doi: 10.3390/nu11010164
|
| 257 |
Pierre Le Bars, Sébastien Matamoros, Emmanuel Montassier, Françoise Le Vacon, Gilles Potel, Assem Soueidan, Fabienne Jordana, Marie-France de La Cochetière. The oral cavity microbiota: between health, oral disease, and cancers of the aerodigestive tract. Canadian Journal of Microbiology 2017; 63(6) doi: 10.1139/cjm-2016-0603
|
| 258 |
Cheng-Bei Zhou, Yi-Lu Zhou, Jing-Yuan Fang. Gut Microbiota in Cancer Immune Response and Immunotherapy. Trends in Cancer 2021; 7(7) doi: 10.1016/j.trecan.2021.01.010
|
| 259 |
Minoru Koi, Yoshiki Okita, John M. Carethers. <i>Fusobacterium nucleatum</i> Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations. Journal of the Anus, Rectum and Colon 2018; 2(2) doi: 10.23922/jarc.2017-055
|
| 260 |
Xiaotao Zhang, Carrie R. Daniel. Inflammation, Infection, and Microbiome in Cancers. Physiology in Health and Disease 2021; doi: 10.1007/978-3-030-67951-4_11
|
| 261 |
Yuyu Zhao, Qianying Tao, Shaoyu Li, Peiyong Zheng, Jianwen Liu, Xin Liang. Both endogenous and exogenous miR-139–5p inhibit Fusobacterium nucleatum-related colorectal cancer development. European Journal of Pharmacology 2020; 888 doi: 10.1016/j.ejphar.2020.173459
|
| 262 |
. 2020; doi: 10.70675/e1f6b965z319dz4eeaz93dfzf68c6bf84e43
|
| 263 |
Charles Maisonneuve, Thergiory Irrazabal, Alberto Martin, Stephen E. Girardin, Dana J. Philpott. The Impact of the Gut Microbiome on Colorectal Cancer. Annual Review of Cancer Biology 2018; 2(1) doi: 10.1146/annurev-cancerbio-030617-050240
|
| 264 |
Anjali Chander, Huile Lim, Gilad Bachrach, Miguel Reis Ferreira. The Dual Face of Fusobacterium nucleatum in Cancer: Foe, Friend or Both?. Journal of Periodontal Research 2026; doi: 10.1111/jre.70165
|
| 265 |
Mahsa Yousefpour Marzbali, Morteza Banakar, Seyyed Mojtaba Mousavi, Chin Wei Lai. Microbial Metagenomics in Effluent Treatment Plant. 2024; doi: 10.1016/B978-0-443-13531-6.00007-0
|
| 266 |
Sofia C. Tortora, Maria Gonzalez Agurto, Laura A. Martello. The oral-gut-circulatory axis: from homeostasis to colon cancer. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1289452
|
| 267 |
Taishi Yamane, Yohei Kanamori, Hiroshi Sawayama, Hiromu Yano, Akihiro Nita, Yudai Ohta, Hironori Hinokuma, Ayato Maeda, Akiko Iwai, Takashi Matsumoto, Mayuko Shimoda, Mayumi Niimura, Shingo Usuki, Noriko Yasuda-Yoshihara, Masato Niwa, Yoshifumi Baba, Takatsugu Ishimoto, Yoshihiro Komohara, Tomohiro Sawa, Tasuku Hirayama, Hideo Baba, Toshiro Moroishi. Iron accelerates Fusobacterium nucleatum–induced CCL8 expression in macrophages and is associated with colorectal cancer progression. JCI Insight 2022; 7(21) doi: 10.1172/jci.insight.156802
|
| 268 |
Sui Wang, Gang Huang, Jue-Xin Wang, Lin Tian, Xiu-Li Zuo, Yan-Qing Li, Yan-Bo Yu. Altered Gut Microbiota in Patients With Peutz–Jeghers Syndrome. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.881508
|
| 269 |
Alana Smith, Xueyuan Cao, Qingqing Gu, Ernestine Kubi Amos-Abanyie, Elizabeth A. Tolley, Gregory Vidal, Beverly Lyn-Cook, Athena Starlard-Davenport. Characterization of the Metabolome of Breast Tissues from Non-Hispanic Black and Non-Hispanic White Women Reveals Correlations between Microbial Dysbiosis and Enhanced Lipid Metabolism Pathways in Triple-Negative Breast Tumors. Cancers 2022; 14(17) doi: 10.3390/cancers14174075
|
| 270 |
Sui Wan, Gang Huang, Jue-Xin Wang, Lin Tian, Xiu-Li Zuo, Qing-Yan Li, Yan-Bo Yu. Altered Gut Microbiota in Patients With Peutz-Jeghers Syndrome. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4022526
|
| 271 |
Li Liu, Fred K. Tabung, Xuehong Zhang, Jonathan A. Nowak, Zhi Rong Qian, Tsuyoshi Hamada, Daniel Nevo, Susan Bullman, Kosuke Mima, Keisuke Kosumi, Annacarolina da Silva, Mingyang Song, Yin Cao, Tyler S. Twombly, Yan Shi, Hongli Liu, Mancang Gu, Hideo Koh, Wanwan Li, Chunxia Du, Yang Chen, Chenxi Li, Wenbin Li, Raaj S. Mehta, Kana Wu, Molin Wang, Aleksander D. Kostic, Marios Giannakis, Wendy S. Garrett, Curtis Hutthenhower, Andrew T. Chan, Charles S. Fuchs, Reiko Nishihara, Shuji Ogino, Edward L. Giovannucci. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum. Clinical Gastroenterology and Hepatology 2018; 16(10) doi: 10.1016/j.cgh.2018.04.030
|
| 272 |
Hiroyuki Yamamoto, Kohzoh Imai. An updated review of microsatellite instability in the era of next-generation sequencing and precision medicine. Seminars in Oncology 2019; 46(3) doi: 10.1053/j.seminoncol.2019.08.003
|
| 273 |
Kate L. F. Johnstone, Sinead Toomey, Stephen Madden, Brian D. P. O’Neill, Bryan T Hennessy. Fusobacterium nucleatum: caution with interpreting historical patient sample cohort. Journal of Pathology and Translational Medicine 2021; 55(6) doi: 10.4132/jptm.2021.08.27
|
| 274 |
Vincenzo Quagliariello, Pietro Forte, Giuliana Ciappina, Luigi Colarusso, Carlotta Giorgi, Francesco Fiorica, Antonio Bottari, Giordana Di Mauro, Nicola Maurea, Massimiliano Berretta. Fusobacteriumnucleatum: Pathophysiological and Clinical Involvement in Inflammatory Bowel Diseases, Colorectal Cancer and Cardiovascular Diseases. Cancers 2025; 17(20) doi: 10.3390/cancers17203348
|
| 275 |
Petra Șurlin, Flavia Mirela Nicolae, Valeriu Marin Șurlin, Ștefan Pătrașcu, Bogdan Silviu Ungureanu, Andreea Cristiana Didilescu, Dan Ionuț Gheonea. Could Periodontal Disease through Periopathogen Fusobacterium nucleatum Be an Aggravating Factor for Gastric Cancer?. Journal of Clinical Medicine 2020; 9(12) doi: 10.3390/jcm9123885
|
| 276 |
Yu Chen, Xiulan Lai. Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer. Mathematical Biosciences 2022; 350 doi: 10.1016/j.mbs.2022.108868
|
| 277 |
Yue‐Mei Hong, Dingka Song, Ning‐Ning Liu, Hui Wang. Development and treatment of colorectal cancer: Insights from multi‐kingdom microbiota. Aging and Cancer 2023; 4(1) doi: 10.1002/aac2.12063
|
| 278 |
Minoru Koi, Stephanie S Tseng-Rogenski, John M Carethers. Inflammation-associated microsatellite alterations: Mechanisms and significance in the prognosis of patients with colorectal cancer. World Journal of Gastrointestinal Oncology 2018; 10(1): 1-14 doi: 10.4251/wjgo.v10.i1.1
|
| 279 |
Marc Hilmi, Cindy Neuzillet, Jérémie H. Lefèvre, Magali Svrcek, Sophie Vacher, Leonor Benhaim, Peggy Dartigues, Emmanuelle Samalin, Julien Lazartigues, Jean-François Emile, Eugénie Rigault, Nathalie Rioux-Leclercq, Christelle de La Fouchardière, David Tougeron, Wulfran Cacheux, Pascale Mariani, Laura Courtois, Matthieu Delaye, Virginie Dangles-Marie, Astrid Lièvre, Ivan Bieche. Prognostic Value of Fusobacterium nucleatum after Abdominoperineal Resection for Anal Squamous Cell Carcinoma. Cancers 2022; 14(7) doi: 10.3390/cancers14071606
|
| 280 |
Na Li, Honghe Xiao, Jiangli Shen, Ximin Qiao, Fenjuan Zhang, Weibo Zhang, Yuan Gao, Yue Dong Liu. SELE gene as a characteristic prognostic biomarker of colorectal cancer. Journal of International Medical Research 2021; 49(4) doi: 10.1177/03000605211004386
|
| 281 |
Robert A. Holt, Kyla Cochrane. Tumor Potentiating Mechanisms of Fusobacterium nucleatum , A Multifaceted Microbe. Gastroenterology 2017; 152(4) doi: 10.1053/j.gastro.2017.01.024
|
| 282 |
Peter Polaček, Vojtěch Fiala, David Feldmar, Martin Matějů, Otakar Čapoun, Viktor Soukup. Intratumoral microbiome in clear cell renal cell carcinoma - a new factor in the tumor microenvironment. Czech Urology 2026; 30(3) doi: 10.48095/cccu2026018
|
| 283 |
Keyi Zhang, Lin Liu, Peiyao Wu, Lei Zhao, Jieyu Zhou, Yafei Wu. Fusobacterium nucleatum exacerbates atherosclerosis progression via ceRNA network-mediated epigenetic reprogramming. Genomics 2026; 118(1) doi: 10.1016/j.ygeno.2025.111186
|
| 284 |
Yoshinori Uchino, Yuichi Goto, Yusuke Konishi, Kan Tanabe, Hiroko Toda, Masumi Wada, Yoshiaki Kita, Mahiro Beppu, Shinichiro Mori, Hiroshi Hijioka, Takao Otsuka, Shoji Natsugoe, Eiji Hara, Tsuyoshi Sugiura. Colorectal Cancer Patients Have Four Specific Bacterial Species in Oral and Gut Microbiota in Common—A Metagenomic Comparison with Healthy Subjects. Cancers 2021; 13(13) doi: 10.3390/cancers13133332
|
| 285 |
Fengjiao Li, Yun Wu, Yujie Yan, Saizhi Wu, Jingyu Zhu, Gaihua Zhang, Peng Zhang, Lianwen Yuan, Yong Zeng, Zhonghua Liu. Transcriptomic landscape of sodium butyrate-induced growth inhibition of human colorectal cancer organoids. Molecular Omics 2022; 18(8) doi: 10.1039/D2MO00127F
|
| 286 |
Olga V. Kovaleva, Polina Podlesnaya, Maxim Sorokin, Valeria Mochalnikova, Vladimir Kataev, Yuriy A. Khlopko, Andrey O. Plotnikov, Ivan S. Stilidi, Nikolay E. Kushlinskii, Alexei Gratchev. Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients’ Survival: A Pilot Study. Biomedicines 2022; 10(7) doi: 10.3390/biomedicines10071516
|
| 287 |
Jacobo Porto-Álvarez, Eva Cernadas, Rebeca Aldaz Martínez, Manuel Fernández-Delgado, Emilio Huelga Zapico, Víctor González-Castro, Sandra Baleato-González, Roberto García-Figueiras, J Ramon Antúnez-López, Miguel Souto-Bayarri. CT-Based Radiomics to Predict KRAS Mutation in CRC Patients Using a Machine Learning Algorithm: A Retrospective Study. Biomedicines 2023; 11(8) doi: 10.3390/biomedicines11082144
|
| 288 |
Kentaro Inamura. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Seminars in Cancer Biology 2021; 70 doi: 10.1016/j.semcancer.2020.06.006
|
| 289 |
Yiqiu Li, Shan Xing, Fangfang Chen, Qifan Li, Shuheng Dou, Yuying Huang, Jun An, Wanli Liu, Ge Zhang. Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-40987-3
|
| 290 |
Elizabeth Clinger, Lei Hao. The Association of Diet-Modulated Gut Microbiota on Development and Treatment of Colorectal Cancer. Journal of Nutritional Oncology 2021; 6(4) doi: 10.34175/jno202104001
|
| 291 |
A. V. Filatov, A. V. Minin, S. V. Nikolaev. The structure of the microbiota of the colon of young pigs is normal and in the pathology of the gastrointestinal tract. Agricultural Science Euro-North-East 2025; 26(2) doi: 10.30766/2072-9081.2025.26.2.388-395
|
| 292 |
William P. Duggan, Batuhan Kisakol, Emer O’Connell, Anna Matveeva, Tony O’Grady, Elizabeth McDonough, Andreas U. Lindner, Deborah McNamara, Daniel Longley, Fiona Ginty, John P. Burke, Jochen H.M. Prehn. Multiplexed Immunofluorescence Imaging Reveals an Immune-Rich Tumor Microenvironment in Mucinous Rectal Cancer Characterized by Increased Lymphocyte Infiltration and Enhanced Programmed Cell Death Protein 1 Expression. Diseases of the Colon & Rectum 2023; 66(7) doi: 10.1097/DCR.0000000000002624
|
| 293 |
Dan Long, Chenhan Mao, Zhensheng Zhang, Junjun Zou, Ying Zhu. Visual analysis of colorectal cancer and gut microbiota: A bibliometric analysis from 2002 to 2022. Medicine 2023; 102(44) doi: 10.1097/MD.0000000000035727
|
| 294 |
Floriana Morgillo, Marcello Dallio, Carminia Maria Della Corte, Antonietta Gerarda Gravina, Giuseppe Viscardi, Carmelina Loguercio, Fortunato Ciardiello, Alessandro Federico. Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota. Neoplasia 2018; 20(7) doi: 10.1016/j.neo.2018.05.002
|
| 295 |
Yujiro Nakayama, Takeru Iijima, Takuhiko Inokuchi, Ekumi Kojika, Misato Takao, Akinari Takao, Koichi Koizumi, Shin-ichiro Horiguchi, Tsunekazu Hishima, Tatsuro Yamaguchi. Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study. International Journal of Clinical Oncology 2021; 26(10) doi: 10.1007/s10147-021-01968-y
|
| 296 |
Rodolfo Mauceri, Martina Coppini, Davide Vacca, Giorgio Bertolazzi, Vera Panzarella, Olga Di Fede, Claudio Tripodo, Giuseppina Campisi. Salivary Microbiota Composition in Patients with Oral Squamous Cell Carcinoma: A Systematic Review. Cancers 2022; 14(21) doi: 10.3390/cancers14215441
|
| 297 |
Yen Chun G. Liu, Shou-Jen Lan, Hirohiko Hirano, Li-min Lin, Kazuhiro Hori, Chia-shu Lin, Samuel Zwetchkenbaum, Shunsuke Minakuchi, Andy Yen-Tung Teng. Update and review of the gerodontology prospective for 2020's: Linking the interactions of oral (hypo)-functions to health vs. systemic diseases. Journal of Dental Sciences 2021; 16(2) doi: 10.1016/j.jds.2020.09.007
|
| 298 |
Stephen J. D. O'Keefe. Diet, microorganisms and their metabolites, and colon cancer. Nature Reviews Gastroenterology & Hepatology 2016; 13(12) doi: 10.1038/nrgastro.2016.165
|
| 299 |
Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí, José Gutiérrez-Fernández. The association between Fusobacterium nucleatum and cancer colorectal: A systematic review and meta-analysis. Enfermedades infecciosas y microbiologia clinica (English ed.) 2022; 40(5) doi: 10.1016/j.eimce.2022.02.007
|
| 300 |
Tao Zuo, Yu Lu, Yue Li. Springer Handbook of Medical Biotechnology. Springer Handbooks 2026; doi: 10.1007/978-3-032-01636-2_37
|
| 301 |
Sara Federici, Jotham Suez, Eran Elinav. Symbiosis: Cellular, Molecular, Medical and Evolutionary Aspects. Results and Problems in Cell Differentiation 2020; 69 doi: 10.1007/978-3-030-51849-3_20
|
| 302 |
Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí, José Gutiérrez-Fernández. La asociación entre Fusobacterium nucleatum y el cáncer colorrectal: una revisión sistemática y metaanálisis. Enfermedades Infecciosas y Microbiología Clínica 2022; 40(5) doi: 10.1016/j.eimc.2021.01.005
|
| 303 |
Peter E. Murray, Jonathan A. Coffman, Franklin Garcia-Godoy. Oral Pathogens’ Substantial Burden on Cancer, Cardiovascular Diseases, Alzheimer’s, Diabetes, and Other Systemic Diseases: A Public Health Crisis—A Comprehensive Review. Pathogens 2024; 13(12) doi: 10.3390/pathogens13121084
|
| 304 |
Kumari Anchu Dogra, Mamta Sharma, Nabanita Ghosh, Gurpreet Kaur, Jaswinder Singh, Priyobrata Sinha. Gut microbiota and immune modulation: role in neurodegenerative disorders and cancer. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-12155-5
|
| 305 |
Shuji Ogino, Jonathan A Nowak, Tsuyoshi Hamada, Amanda I Phipps, Ulrike Peters, Danny A Milner Jr, Edward L Giovannucci, Reiko Nishihara, Marios Giannakis, Wendy S Garrett, Mingyang Song. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut 2018; 67(6) doi: 10.1136/gutjnl-2017-315537
|
| 306 |
Xin-Zhu Du, Bin Wen, Lin Liu, Ying-Ting Wei, Kui Zhao. Role of immune escape in different digestive tumours. World Journal of Clinical Cases 2021; 9(34): 10438-10450 doi: 10.12998/wjcc.v9.i34.10438
|
| 307 |
Haiyun Shang, Xiaoting Zhang, Hao Su, Hongyan Chen, Na Qin, Huarong Chen. Novel Therapeutic Targeting in Cancer: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2024; 26 doi: 10.1007/16833_2024_298
|
| 308 |
Frank A Sinicrope, Qian Shi, Fabienne Hermitte, Tyler J Zemla, Bernhard Mlecnik, Al B Benson, Sharlene Gill, Richard M Goldberg, Morton S Kahlenberg, Suresh G Nair, Anthony F Shields, Thomas C Smyrk, Jerome Galon, Steven R Alberts. Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer. JNCI Cancer Spectrum 2020; 4(3) doi: 10.1093/jncics/pkaa023
|
| 309 |
Marie S. Rye, Kerryn L. Garrett, Robert A. Holt, Cameron F. Platell, Melanie J. McCoy, Jonathan Jacobs. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load. PLOS ONE 2022; 17(1) doi: 10.1371/journal.pone.0262416
|
| 310 |
Xuqiang Zhang, Yuxin Wang, Ruochen Fan, Liying Zhang, Zhuting Li, Yanmei Zhang, Wei Zheng, Lulu Wang, Baoquan Liu, Chunshan Quan, Sadjia Bekal. Quantitative Proteomic Analysis of Outer Membrane Vesicles from Fusobacterium nucleatum Cultivated in the Mimic Cancer Environment. Microbiology Spectrum 2023; 11(4) doi: 10.1128/spectrum.00394-23
|
| 311 |
Abhik Saha, Erle S. Robertson. Microbiome and Cancer. Current Cancer Research 2019; doi: 10.1007/978-3-030-04155-7_1
|
| 312 |
Baoyi Zhang, Kevin Yao, Emily Zhou, Lanjing Zhang, Chao Cheng. Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer. Cancer Research 2021; 81(8) doi: 10.1158/0008-5472.CAN-20-4009
|
| 313 |
Valter R.M. Lombardi, Iván Carrera, Lola Corzo, Ramón Cacabelos. Role of bioactive lipofishins in prevention of inflammation and colon cancer. Seminars in Cancer Biology 2019; 56 doi: 10.1016/j.semcancer.2017.11.012
|
| 314 |
Manuela Salvucci, Nyree Crawford, Katie Stott, Susan Bullman, Daniel B Longley, Jochen H M Prehn. Patients with mesenchymal tumours and highFusobacterialesprevalence have worse prognosis in colorectal cancer (CRC). Gut 2021; doi: 10.1136/gutjnl-2021-325193
|
| 315 |
Xuan Zhao, Jiaman Pang, Wanghong Zhang, Xie Peng, Zhenguo Yang, Guangdong Bai, Yaoyao Xia. Tryptophan metabolism and piglet diarrhea: Where we stand and the challenges ahead. Animal Nutrition 2024; 17 doi: 10.1016/j.aninu.2024.03.005
|
| 316 |
Qiaoli Yang, Xiaoyu Huang, Pengfei Wang, Zunqiang Yan, Wenyang Sun, Shengguo Zhao, Shuangbao Gun. Longitudinal development of the gut microbiota in healthy and diarrheic piglets induced by age‐related dietary changes. MicrobiologyOpen 2019; 8(12) doi: 10.1002/mbo3.923
|
| 317 |
Seyedeh Zahra Bakhti, Saeid Latifi-Navid. Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next?. BMC Microbiology 2021; 21(1) doi: 10.1186/s12866-021-02130-4
|
| 318 |
Rongjin Luo, Yanmin Chang, Huaizhen Liang, Weifeng Zhang, Yu Song, Gaocai Li, Cao Yang. Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities. iMeta 2023; 2(2) doi: 10.1002/imt2.86
|